Document:

EX-4.2

 Exhibit 4.2 

MINDBODY, INC. 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

This Amended and Restated Investors’ Rights Agreement (this “Agreement”) is made and entered into as of
February 10, 2014, by and among Mindbody, Inc., a California corporation (the “Company”), the holders of outstanding Common Stock of the Company listed on Schedule 1 hereto (the “Founders”), the
holders of outstanding Series A Preferred Stock and Series B Preferred Stock of the Company listed on Schedule 2 hereto (the “Series A and B Holders”), the holders of outstanding Series C Preferred
Stock of the Company listed on Schedule 3 hereto (the “Series C Holders”), the holders of outstanding Series D Preferred Stock of the Company listed on Schedule 4 hereto (the “Series D
Holders”), the holders of Series E Preferred Stock of the Company listed on Schedule 5 hereto (the “Series E Holders”), the holders of Series F Preferred Stock of the Company listed on
Schedule 6 hereto (the “Series F Holders”) and the purchasers of Series G Preferred Stock of the Company listed on Schedule 7 hereto (the “New Investors” and, together with the
Series A and B Holders, the Series C Holders, the Series D Holders, the Series E Holders and the Series F Holders, the “Investors”). 

RECITALS 
 The
Company, the Founders, the Series A and B Holders, the Series C Holders, the Series D Holders, the Series E Holders and the Series F Holders previously entered into an Amended and Restated Investors’ Rights Agreement
dated as of October 19, 2012 (the “Prior Agreement”). The Company and the New Investors have entered into a Series G Preferred Stock Purchase Agreement (the “Purchase Agreement”) dated as of the date
hereof, pursuant to which the Company desires to sell to the New Investors and the New Investors desire to purchase from the Company shares of the Company’s Series G Preferred Stock (the “Series G Preferred Stock”). A
condition to the New Investors’ obligations under the Purchase Agreement is that the Company, the Founders and the Investors enter into this Agreement in order to provide (i) the Investors and the Founders certain rights to register shares
of the Company’s common stock (the “Common Stock”) held by the Investors and the Founders or issued or issuable upon conversion of the Company’s preferred stock (the “Preferred Stock”) held by the
Investors, (ii) the Investors certain rights to receive or inspect information pertaining to the Company, and (iii) the Investors a right of first offer with respect to certain issuances by the Company of its securities. The Company, the
Founders, the Series A and B Holders, the Series C Holders, the Series D Holders, the Series E Holders and the Series F Holders desire to induce the New Investors to purchase shares of Series G Preferred Stock pursuant
to the Purchase Agreement by agreeing to the terms and conditions set forth below. 
 Section 5.3 of the Prior Agreement provides that
the Prior Agreement may be amended and restated as provided herein upon the written consent of (i) the Company, (ii) the Required Other Holders (as defined in the Prior Agreement), and (iii) the holders of not less than a majority of
the of the outstanding shares of Series C Registrable Securities, Series D Registrable Securities, Series E Registrable Securities and Series F Registrable Securities (in each case, on an as-converted basis), voting together as a
single class (collectively, the “Required Holders”). 

 AGREEMENT 

The parties agree as follows: 

1. Amendment of Prior Agreement; Waiver of Right of First Offer. Effective and contingent upon (a) execution of this
Agreement by the Required Holders, and (b) upon the Closing (as such term is defined in Purchase Agreement), the Prior Agreement is hereby amended and restated in its entirety to read as set forth in this Agreement, and the Company and the
Investors agree (i) to be bound by the provisions hereof as the sole agreement of the Company, the Founders and the Investors with respect to the registration rights of the Company’s securities and certain other rights, as set forth
herein, and (ii) that the provisions of the Prior Agreement shall have no further force and effect with respect to the Company, the Founders, the Series A and B Holders, the Series C Holders, the Series D Holders, the
Series E Holders or the Series F Holders. The Series A and B Holders, the Series C Holders, the Series D Holders, the Series E Holders and the Series F Holders that are Major Investors (as that term is defined in
the Prior Agreement) hereby waive the Right of First Offer, including the notice requirements, set forth in the Prior Agreement with respect to the issuance of Series G Preferred Stock pursuant to the Purchase Agreement. 

2. Registration Rights. 

2.1 Definitions. For purposes of this Agreement: 

(a) “Exchange Act” means the Securities Exchange Act of 1934, as amended (and any successor thereto), and the rules and
regulations promulgated thereunder. 
 (b) “Excluded Registration” means a registration (i) on Form S-4 or Form S-8
promulgated under the Securities Act or any successor forms thereto, (ii) in connection with an exchange offer or offering solely to the Company’s stockholders, (iii) on Form S-1 or any successor form thereto in connection with
an exchange of shares in connection with a merger or acquisition conducted or contemplated by the Company, (iv) relating solely to the sale of securities to participants in a Company stock plan, or (v) relating solely to a transaction
covered by Rule 145 under the Securities Act. 
 (c) “Form S-3” means such form under the Securities Act as in effect on
the date hereof or any successor form under the Securities Act that permits significant incorporation by reference of the Company’s subsequent public filings under the Exchange Act. 

(d) “Founders’ Stock” means the shares of Common Stock issued to or owned by the Founders. 

(e) “Holder” means any person owning or having the right to acquire Registrable Securities or any assignee thereof in
accordance with Section 2.12 of this Agreement. 
 (f) “Other Registrable Securities” means Registrable Securities
held by the Series A and B Holders, the Founders or their permitted successors and assigns. 

  
 -2- 

 (g) “Qualifying IPO” has the meaning given to such term in the Restated
Articles. 
 (h) “register,” “registered,” and “registration” refer to a registration
effected by preparing and filing a registration statement or similar document in compliance with the Securities Act, and the declaration or ordering of effectiveness of such registration statement or document. 

(i) “Registrable Securities” means (i) the shares of Common Stock issuable or issued upon conversion of the Preferred
Stock, (ii) the shares of Founders’ Stock, (iii) any other shares of Common Stock held by the Founders, the Investors or their permitted successors and assigns at any time and (iv) any other shares of Common Stock of the Company
issued as (or issuable upon the conversion or exercise of any warrant, right or other security which is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of, the shares listed in (i), (ii) and
(iii); provided, however, that the foregoing definition shall exclude in all cases any Registrable Securities sold by a person in a transaction in which such person’s rights under this Agreement are not assigned, other than in accordance with
Section 2.12. Notwithstanding the foregoing, except for purposes of Section 5.3, Common Stock or other securities shall only be treated as Registrable Securities if and so long as (A) they have not been sold to or through a broker or
dealer or underwriter in a public distribution or a public securities transaction, (B) they have not been sold in a transaction exempt from the registration and prospectus delivery requirements of the Securities Act under Section 4(1)
thereof so that all transfer restrictions, and restrictive legends with respect thereto, if any, are removed upon the consummation of such sale, or (C) the Holder thereof is entitled to exercise any right provided in Section 2 in
accordance with Section 2.14 below. 
 (j) “Registrable Securities then outstanding” shall be determined by the
number of shares of Common Stock outstanding which are, and the number of shares of Common Stock issuable pursuant to then exercisable or convertible securities which are, Registrable Securities. 

(k) “Required Other Holders” means the holders of a majority of the Other Registrable Securities. 

(l) “Required Series C Holders” means the holders of a majority of the Series C Registrable Securities. 

(m) “Required Series D, E, F and G Holders” means the holders of a majority of the Series D Registrable
Securities, Series E Registrable Securities, Series F and Series G Registrable Securities, voting together. 
 (n)
“Restated Articles” means the Company’s Sixth Amended and Restated Articles of Incorporation. 
 (o) “Right
of First Refusal and Co-Sale Agreement” means the Amended and Restated Right of First Refusal and Co-Sale Agreement, dated as of the date hereof, by and among the Company, the Founders, the Investors and the other parties thereto, as the
same may be amended, restated and otherwise modified from time to time. 

  
 -3- 

 (p) “SEC” means the U.S. Securities and Exchange Commission. 

(q) “Securities Act” means the U.S. Securities Act of 1933, as amended (and any successor thereto), and the rules and
regulations promulgated thereunder. 
 (r) “Series C Registrable Securities” means Registrable Securities held by the
Series C Holders or their permitted successors and assigns. 
 (s) “Series D Registrable Securities” means
Registrable Securities held by the Series D Holders or their permitted successors and assigns. 
 (t) “Series E
Registrable Securities” means Registrable Securities held by the Series E Holders or their permitted successors and assigns 

(u) “Series F Registrable Securities” means Registrable Securities held by the Series F Holders or their permitted
successors and assigns. 
 (v) “Series G Registrable Securities” means Registrable Securities held by the New
Investors or their permitted successors and assigns. 
 (w) “Voting Agreement” means the Amended and Restated Voting
Agreement, dated as of the date hereof, by and among the Company, the Founders, the Investors and the other parties thereto, as the same may be amended, restated and otherwise modified from time to time. 

2.2 Request for Registration. 

(a) If the Company shall receive at any time after six (6) months after the effective date of the first registration statement for an
underwritten public offering of securities of the Company (other than an Excluded Registration), a written request from either the Required Series D, E, F and G Holders (a “Series D, E, F and G Demand Registration”), the
Required Series C Holders (a “Series C Demand Registration”) or the Required Other Holders (an “Other Shareholder Demand Registration”) that the Company file a registration statement under the Securities
Act covering the registration of at least such number of the Registrable Securities having an anticipated aggregate offering price of at least $5,000,000, then the Company shall, within 10 days of the receipt thereof, give written notice of such
request to all Holders and shall, subject to the limitations of subsection 2.2(b), use its best efforts to file as soon as practicable, and in any event within 90 days of the receipt of such request, a registration statement under the
Securities Act covering all Registrable Securities which the Holders request to be registered within 20 days of the mailing of such notice by the Company. 

(b) If the Holders initiating the registration request under Section 2.2(a) (“Initiating Holders”) intend to distribute
the Registrable Securities covered by their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to this Section 2.2 and the Company shall include such information in the written notice
referred to in subsection 2.2(a). The underwriter will be selected by a majority in interest of the Initiating Holders and shall be reasonably acceptable to the Company. In such event, the right of any Holder to include his or its Registrable
Securities in such registration shall 

  
 -4- 

 
be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting (unless otherwise mutually agreed by a
majority in interest of the Initiating Holders and such Holder) to the extent provided herein. All Holders proposing to distribute their securities through such underwriting shall (together with the Company as provided in subsection 2.5(e))
enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such underwriting. 
 (c)
Notwithstanding the foregoing, if the Company shall furnish to Holders requesting a registration statement pursuant to this Section 2.2, a certificate signed by the President of the Company stating that in the good faith judgment of the Board
of Directors of the Company, it would be seriously detrimental to the Company and its holders of capital stock for such registration statement to be filed and it is therefore essential to defer the filing of such registration statement, the Company
shall have the right to defer such filing for a period of not more than 120 days after receipt of the request of the Initiating Holders; provided, however, that the Company may not utilize this right (collectively with the similar right under
subsection 2.4(b)) more than once in any twelve-month period. 
 (d) In addition, the Company shall not be obligated to effect, or to
take any action to effect, any registration pursuant to this Section 2.2: 
 (i) (A) if the Initiating Holders are holders of
Series D Registrable Securities, Series E Registrable Securities, Series F Registrable Securities or Series G Registrable Securities and the Company has either (1) effected one (1) Series D, E, F and G Demand
Registration in the prior twelve (12) months, or (2) previously effected two (2) Series D, E, F and G Demand Registrations in the aggregate, and such registrations have been declared or ordered effective and at least 90% of the
Series D Registrable Securities, Series E Registrable Securities, Series F Registrable Securities and Series G Registrable Securities requested to be included therein were able to be registered and sold thereunder, (B) if
the Initiating Holders are holders of Series C Registrable Securities and the Company has either (1) effected one (1) Series C Demand Registration in the prior twelve (12) months, or (2) previously effected two
(2) Series C Demand Registrations in the aggregate, and such registrations have been declared or ordered effective and at least 90% of the Series C Registrable Securities requested to be included therein were able to be registered and
sold thereunder or (C) if the Initiating Holders are holders of Other Registrable Securities and the Company has either (1) effected one (1) Other Shareholders Demand Registration in the prior twelve (12) months, or
(2) previously effected two (2) Other Shareholders Demand Registrations in the aggregate, and such registrations have been declared or ordered effective and at least 90% of the Other Registrable Securities requested to be included therein
were able to be registered and sold thereunder; 
 (ii) if the Company has, within the 12-month period preceding the date of such request,
already effected one registration for the Holders pursuant to this Section 2.2, and such registration has been declared or ordered effective and at least 90% of the Registrable Securities requested to be included therein were able to be
registered and sold thereunder; 

  
 -5- 

 (iii) during the period starting with the date 90 days prior to the Company’s good faith
estimate of the date of filing of, and ending on a date 90 days after the effective date of, a registration subject to Section 2.3; provided that the Company is actively employing in good faith all reasonable efforts to cause such registration
statement to become effective; or 
 (iv) if the Initiating Holders propose to dispose of shares of Registrable Securities that may be
immediately registered on Form S-3 pursuant to a request made pursuant to Section 2.4. 
 (e) If the total amount of securities,
including Registrable Securities, requested by holders of capital stock and the Company to be included in an underwritten Series D, E, F and G Demand Registration, Series C Demand Registration, Other Shareholder Demand Registration or
registration requested under Section 2.4 exceeds the amount of securities that the underwriters determine in their sole discretion is compatible with the success of the offering, then the Company shall be required to include in the offering
only that number of such securities, including Registrable Securities, which the underwriters determine in their sole discretion will not jeopardize the success of the offering, and the Company will include in such registration (i) first, the
number of Registrable Securities (apportioned pro rata among the selling Holders according to the total amount of securities entitled to be included therein owned by each selling Holder or in such other proportions as shall mutually be agreed to by
such selling Holders), but in no event shall any Other Registrable Securities be included until Holders of Series G Registrable Securities, Series F Registrable Securities, Series E Registrable Securities, Series D Registrable
Securities and Series C Registrable Securities that have requested to include Registrable Securities therein shall have received (or will receive in such registration) an amount equal to the original purchase price of their shares of
Series G Preferred Stock, Series F Preferred Stock, Series E Preferred Stock, Series D Preferred Stock and Series C Preferred Stock, respectively, (ii) second, the securities, if any, the Company proposes to sell
therein and (iii) third, any other securities of the Company requested to be included in such registration. For purposes of the preceding parenthetical concerning apportionment, for any selling Holder which is a partnership or corporation, the
partners, retired partners, holders of capital stock of such Holder, the estates and family members of any such partners and retired partners, any Affiliated Fund (as defined below) and any trusts for the benefit of any of the foregoing persons
shall be deemed to be a single “selling Holder,” and any pro-rata reduction with respect to such “selling security holder” shall be based upon the aggregate amount of shares carrying registration rights owned by all
entities and individuals included in such “selling Holder,” as defined in this sentence. 
 2.3 Company
Registration. If (but without any obligation to do so) the Company proposes to register (including for this purpose a registration effected by the Company for holders of capital stock other than the Holders) any of its stock under the
Securities Act in connection with the public offering of such securities solely for cash (other than a registration relating solely to the sale of securities to participants in a Company stock plan or a transaction covered by Rule 145 under the
Securities Act, a registration in which the only stock being registered is Common Stock issuable upon conversion of debt securities which are also being registered, or any registration on any form which does not include substantially the same
information as would be required to be included in a registration statement covering the sale of 

  
 -6- 

 
the Registrable Securities), the Company shall, at such time, promptly give each Holder written notice of such registration. Upon the written request of each Holder given within 20 days after
mailing of such notice by the Company in accordance with Section 5.4, the Company shall, subject to the cut back provisions of Section 2.8, cause to be registered under the Securities Act all of the Registrable Securities that each such
Holder has requested to be registered. 
 2.4 Form S-3 Registration. In case the Company shall receive from any Holder a
written request or requests that the Company effect a registration on Form S-3 and any related qualification or compliance with respect to all or a part of the Registrable Securities owned by such Holder or Holders, the Company will: 

(a) promptly give written notice of the proposed registration, and any related qualification or compliance, to all other Holders; and 

(b) as soon as practicable, effect such registration and all such qualifications and compliances as may be so requested and as would permit
or facilitate the sale and distribution of all or such portion of such Holder’s or Holders’ Registrable Securities as are specified in such request, together with all or such portion of the Registrable Securities of any other Holder or
Holders joining in such request as are specified in a written request given within 15 days after receipt of such written notice from the Company; provided, however, that the Company shall not be obligated to effect any such registration,
qualification or compliance, pursuant to this Section 2.4: (i) if Form S-3 is not available for such offering by the Holders; (ii) if the Holders, together with the holders of any other securities of the Company entitled to inclusion
in such registration, propose to sell Registrable Securities and such other securities (if any) at an aggregate price to the public (net of any underwriters’ discounts or commissions) of less than $1,000,000; (iii) if the Company shall
furnish to the Holders a certificate signed by the President of the Company stating that in the good faith judgment of the Board of Directors of the Company, it would be seriously detrimental to the Company and its holders of capital stock for such
Form S-3 registration to be effected at such time, in which event the Company shall have the right to defer the filing of the Form S-3 registration statement for a period of not more than 120 days after receipt of the request of the Holder or
Holders under this Section 2.4; provided, however, that the Company shall not utilize this right (collectively with the similar right under subsection 2.2(c)) more than once in any 12-month period; (iv) if the Company has, within the
12-month period preceding the date of such request, already effected one registration on Form S-3 for the Holders pursuant to this Section 2.4; (v) in any particular jurisdiction in which the Company
would be required to qualify to do business or to execute a general consent to service of process in effecting such registration, qualification or compliance where the Company is not otherwise qualified or subject to the jurisdiction thereof; or
(vi) during the period ending 180 days after the effective date of a registration statement subject to Section 2.3. 
 (c)
Subject to the foregoing, the Company shall file a registration statement covering the Registrable Securities and other securities so requested to be registered as soon as practicable after receipt of the request or requests of the Holders.
Registrations effected pursuant to this Section 2.4 shall not be counted as demands for registration or registrations effected pursuant to Sections 2.2 or 2.3, respectively. 

  
 -7- 

 2.5 Obligations of the Company. Whenever required under this Section 2 to
effect the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible: 
 (a) Prepare and file
with the SEC a registration statement with respect to such Registrable Securities and use its best efforts to cause such registration statement to become effective, and, upon the request of the Holders of a majority of the Registrable Securities
registered thereunder, keep such registration statement effective for up to 120 days, or until the distribution described in such registration statement is completed, if earlier. 

(b) Prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection with
such registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such registration statement for up to 120 days, or until the distribution described in
such registration statement is completed, if earlier. 
 (c) Furnish to the Holders such numbers of copies of a prospectus, including a
preliminary prospectus, in conformity with the requirements of the Securities Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them. 

(d) Use its best efforts to register and qualify the securities covered by such registration statement under such other securities or Blue
Sky laws of such jurisdictions as shall be reasonably requested by the Holders, provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service of
process in any such states or jurisdictions where the Company is not otherwise qualified or subject to the jurisdiction thereof, except as may be required by the Securities Act. 

(e) In the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and
customary form, with the managing underwriter of such offering. Each Holder participating in such underwriting shall also enter into and perform its obligations under such an agreement. 

(f) Notify each Holder of Registrable Securities covered by such registration statement at any time when a prospectus relating thereto is
required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a
material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing, and at the request of any such Holder, prepare and furnish to such Holder a reasonable number of
copies of a supplement or an amendment of such prospectus as may be necessary so that, as thereafter delivered to purchasers of such Registrable Securities, such prospectus shall not include an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing, such obligation to continue for 120 days. 

  
 -8- 

 (g) Cause all such Registrable Securities registered pursuant hereunder to be listed on each
securities exchange on which similar securities issued by the Company are then listed. 
 (h) Provide a transfer agent and registrar for
all Registrable Securities registered pursuant hereunder and a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration. 

(i) Use its commercially reasonable efforts to furnish, at the request of any Holder requesting registration of Registrable Securities
pursuant to this Section 2, on the date that such Registrable Securities are delivered to the underwriters for sale in connection with a registration pursuant to this Section 2, if such securities are being sold through underwriters,
(i) an opinion, dated such date, of the counsel representing the Company for the purposes of such registration, in form and substance as is customarily given to underwriters in an underwritten public offering, addressed to the underwriters and
(ii) a letter dated such date, from the independent certified public accountants of the Company, in form and substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering,
addressed to the underwriters. 
 (j) Promptly make available for inspection by the selling Holders, any managing underwriter(s)
participating in any disposition pursuant to such registration statement, and any attorney or accountant or other agent retained by any such underwriter or selected by the selling Holders, all financial and other records, pertinent corporate
documents, and properties of the Company, and cause the Company’s officers, directors, employees, and independent accountants to supply all information reasonably requested by any such seller, underwriter, attorney, accountant, or agent, in
each case, as necessary or advisable to verify the accuracy of the information in such registration statement and to conduct appropriate due diligence in connection therewith. 

2.6 Furnish Information. It shall be a condition precedent to the obligations of the Company to take any action pursuant to this
Section 2 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended method of disposition of such
securities as shall be required to effect the registration of such Holder’s Registrable Securities. The Company shall have no obligation with respect to any registration requested pursuant to Section 2.2 or Section 2.4 of this
Agreement if, as a result of the application of the preceding sentence, the number of shares or the anticipated aggregate offering price of the Registrable Securities to be included in the registration does not equal or exceed the number of shares
or the anticipated aggregate offering price required to originally trigger the Company’s obligation to initiate such registration as specified in subsection 2.2(a) or subsection 2.4(b), whichever is applicable. 

2.7 Expenses of Registration. 

(a) Demand Registration. All expenses (other than underwriting discounts and commissions and stock transfer taxes) incurred in
connection with registrations, filings or qualifications pursuant to Section 2.2, including (without limitation) all registration, 

  
 -9- 

 
filing and qualification fees, printers’ and accounting fees, fees and disbursements of counsel for the Company, and the reasonable fees and disbursements of one counsel for the selling
Holders selected by the original requesting Holders with the approval of the Company, which approval shall not be unreasonably withheld, shall be borne by the Company; provided, however, that the Company shall not be required to pay for any expenses
of any registration proceeding begun pursuant to Section 2.2 if the registration request is subsequently withdrawn at the request of the Holders who originally requested such registration (in which case, such Holders shall bear such expenses)
unless the Holders who originally requested such registration agree to forfeit their right to one demand registration pursuant to Section 2.2; provided, further, however, that if at the time of such withdrawal, the Holders (i) have learned
of a material adverse change in the condition, business, or prospects of the Company that was not known to the Holders at the time of their request and (ii) have withdrawn the request with reasonable promptness following disclosure by the
Company of such material adverse change, then the Holders shall not be required to pay any of such expenses and shall not forfeit their rights pursuant to Section 2.2. 

(b) Company Registration. All expenses (other than underwriting discounts and commissions and stock transfer taxes) incurred in
connection with registrations, filings or qualifications of Registrable Securities pursuant to Section 2.3 for each Holder, including (without limitation) all registration, filing, and qualification fees, printers’ and accounting fees,
fees and disbursements of counsel for the Company and the reasonable fees and disbursements of one counsel for the selling Holder or Holders selected by them (by vote of the Holders holding at least a majority of the Registrable Securities requested
to be included therein) with the approval of the Company, which approval shall not be unreasonably withheld, shall be borne by the Company. 

(c) Registration on Form S-3. All expenses (other than underwriting discounts and commissions and stock transfer taxes)
incurred in connection with a registration, filing or qualification requested pursuant to Section 2.4, including (without limitation) all registration, filing, qualification, printers’ and accounting fees and the reasonable fees and
disbursements of one counsel for the selling Holder or Holders selected by the original requesting Holders with the approval of the Company, which approval shall not be unreasonably withheld, and counsel for the Company, shall be borne by the
Company. 
 2.8 Underwriting Requirements. In connection with any offering involving an underwriting of shares of the
Company’s capital stock, the Company shall not be required under Section 2.3 to include any of the Holders’ securities in such underwriting unless they accept the terms of the underwriting as agreed upon between the Company and the
underwriters selected by it (or by other persons entitled to select the underwriters), and then only in such quantity as the underwriters determine in their sole discretion will not jeopardize the success of the offering by the Company. If the total
amount of securities, including Registrable Securities, requested by holders of capital stock to be included in such offering exceeds the amount of securities sold other than by the Company that the underwriters determine in their sole discretion is
compatible with the success of the offering, then the Company shall be required to include in the offering only that number of such securities, including Registrable Securities, which the underwriters determine in their sole discretion will not
jeopardize the success of the offering (the securities so included to be apportioned pro rata among the selling security holders according to the total amount of securities entitled to be included therein owned by each selling security

  
 -10- 

 
holder or in such other proportions as shall mutually be agreed to by such selling security holders) but in no event shall (a) the amount of securities of the selling Holders included in the
offering be reduced below 20% of the total amount of securities included in such offering, unless such offering is the initial public offering of the Company’s securities, in which case, the selling security holders may be excluded if the
underwriters make the determination described above and no other security holder’s securities are included or (b) any Other Registrable Securities be included until Holders of Series G Registrable Securities, Series F Registrable
Securities, Series E Registrable Securities, Series D Registrable Securities and Series C Registrable Securities that have requested to include Registrable Securities therein shall have received (or will receive in such registration)
an amount equal to the original purchase price of their shares of Series G Preferred Stock, Series F Preferred Stock, Series E Preferred Stock, Series D Preferred Stock and Series C Preferred Stock, respectively. For
purposes of the preceding parenthetical concerning apportionment, for any selling security holder which is a partnership or corporation, the partners, retired partners, holders of capital stock of such holder, the estates and family members of any
such partners and retired partners, any Affiliated Fund, and any trusts for the benefit of any of the foregoing persons shall be deemed to be a single “selling security holder,” and any pro-rata reduction with respect to such
“selling security holder” shall be based upon the aggregate amount of shares carrying registration rights owned by all entities and individuals included in such “selling security holder,” as defined in this sentence. 

2.9 Delay of Registration. No Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any
such registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2. 

2.10 Indemnification. In the event any Registrable Securities are included in a registration statement under this
Section 2: 
 (a) To the extent permitted by law, the Company will indemnify and hold harmless each Holder, the partners, officers,
directors and security holders of each Holder, legal counsel and accountants for each Holder, any underwriter (as defined in the Securities Act) for such Holder and each person, if any, who controls such Holder or underwriter within the meaning of
the Securities Act or the Exchange Act, against any losses, claims, damages, or liabilities (joint or several) to which they may become subject under the Securities Act, the Exchange Act or other federal or state law, insofar as such losses, claims,
damages, or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively a “Violation”): (i) any untrue statement or alleged untrue statement
of a material fact contained in such registration statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto, (ii) the omission or alleged omission to state therein a material
fact required to be stated therein, or necessary to make the statements therein not misleading, or (iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any state securities law or any rule or
regulation promulgated under the Securities Act, the Exchange Act or any state securities law; and the Company will pay to each such Holder, underwriter or controlling person, as incurred, any legal or other expenses reasonably incurred by them in
connection with investigating or defending any such loss, claim, damage, liability, or action; provided, however, that the indemnity agreement contained in this subsection 2.10(a) shall not apply to amounts paid

  
 -11- 

 
in settlement of any such loss, claim, damage, liability, or action if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld,
conditioned or delayed), nor shall the Company be liable to any Holder, underwriter or controlling person for any such loss, claim, damage, liability, or action to the extent that it arises out of or is based upon a Violation which occurs in
reliance upon and in conformity with written information furnished expressly for use in connection with such registration by such Holder, underwriter or controlling person. 

(b) To the extent permitted by law, each selling Holder will indemnify and hold harmless the Company, each of its directors, each of its
officers who has signed the registration statement, each person, if any, who controls the Company within the meaning of the Securities Act, any underwriter, any other Holder selling securities in such registration statement and any controlling
person of any such underwriter or other Holder, against any losses, claims, damages, or liabilities (joint or several) to which any of the foregoing persons may become subject, under the Securities Act, the Exchange Act or other federal or state
law, insofar as such losses, claims, damages, or liabilities (or actions in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in
conformity with written information furnished by such Holder expressly for use in connection with such registration; and such Holder will pay, as incurred, any legal or other expenses reasonably incurred by any person intended to be indemnified
pursuant to this subsection 2.10(b), in connection with investigating or defending any such loss, claim, damage, liability, or action; provided, however, that the indemnity agreement contained in this subsection 2.10(b) shall not apply to
amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Holder, which consent shall not be unreasonably withheld, conditioned or delayed; provided that (i) in no
event shall any indemnity under this subsection 2.10(a) exceed the net proceeds from the offering received by such Holder, except in the case of willful fraud by such Holder and (ii) the obligation by each selling Holder to indemnify
hereunder shall be individual and not joint and several for each such Holder. 
 (c) Promptly after receipt by an indemnified party under
this Section 2.10 of notice of the commencement of any action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 2.10, deliver to
the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed,
to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties which may be represented without conflict by one counsel) shall have the right
to retain one separate counsel, with the reasonable fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or
potential differing interests between such indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such
action, if and only to the extent that it is actually prejudicial to its ability to defend such action, shall relieve such indemnifying party of any liability to the indemnified party under this Section 2.10, but the omission so to deliver
written notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party otherwise than under this Section 2.10. 

  
 -12- 

 (d) If the indemnification provided for in this Section 2.10 is held by a court of
competent jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim, damage or expense referred to therein, then the indemnifying party, in lieu of indemnifying such indemnified party hereunder, shall
contribute to the amount paid or payable by such indemnified party as a result of such loss, liability, claim, damage, or expense in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and of the
indemnified party on the other in connection with the statements or omissions that resulted in such loss, liability, claim, damage or expense as well as any other relevant equitable considerations; provided that in no event shall any contribution by
a Holder under this Subsection 2.10(d) exceed the net proceeds from the offering received by such Holder, except in the case of willful fraud by such Holder. The relative fault of the indemnifying party and of the indemnified party shall be
determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the
parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission. 
 (e)
Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing
provisions, the provisions in the underwriting agreement shall control. 
 (f) The obligations of the Company and Holders under this
Section 2.10 shall survive the completion of any offering of Registrable Securities in a registration statement under this Section 2, and otherwise. 

2.11 Reports Under the Exchange Act. With a view to making available to the Holders the benefits of Rule 144 promulgated under
the Securities Act and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on Form S-3, the Company shall use its
commercially reasonable efforts to: 
 (a) make and keep public information available, as those terms are understood and defined in SEC
Rule 144, at all times after 90 days after the effective date of the first registration statement filed by the Company for the offering of its securities to the general public so long as the Company remains subject to the periodic reporting
requirements under Sections 13 or 15(d) of the Exchange Act; 
 (b) take such action, including the voluntary registration of its Common
Stock under Section 12 of the Exchange Act, as is necessary to enable the Holders to utilize Form S-3 for the sale of their Registrable Securities, such action to be taken as soon as practicable after the end of the fiscal year in which the
first registration statement filed by the Company for the offering of its securities to the general public is declared effective; 

  
 -13- 

 (c) file with the SEC in a timely manner all reports and other documents required of the Company
under the Securities Act and the Exchange Act; and 
 (d) furnish to any Holder, so long as the Holder owns any Registrable Securities,
forthwith upon request (i) a written statement by the Company that it has complied with the reporting requirements of SEC Rule 144 (at any time after 90 days after the effective date of the first registration statement filed by the Company),
the Securities Act and the Exchange Act (at any time after it has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form S-3 (at any time after it so qualifies),
(ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company, and (iii) such other information as may be reasonably requested in availing any Holder of any rule or
regulation of the SEC which permits the selling of any such securities without registration or pursuant to such form. 
 2.12
Assignment of Registration Rights. The rights to cause the Company to register Registrable Securities pursuant to this Section 2 may be assigned (but only with all related obligations) by a Holder to a transferee or assignee
(i) of at least 10% of the transferring Holder’s aggregate Registrable Securities originally obtained from the Company (as adjusted for stock splits, stock dividends or the like) or such lower number of Registrable Securities which
represent all such Registrable Securities then held by such Holder, (ii) that is a subsidiary, parent, partner, limited partner, retired partner, member, retired member or holder of capital stock of a Holder, (iii) that is an affiliated
fund or entity of the Holder, which means with respect to a limited liability company, a limited partnership or a limited liability partnership, a fund or entity managed by the same manager or managing member or general partner or management company
or by an entity controlling, controlled by, or under common control with such manager or managing member or general partner or management company (such a fund or entity, an “Affiliated Fund”), (iv) who is a Holder’s child,
stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law (such a relation, a Holder’s “Immediate Family Member”, which
term shall include adoptive relationships), or (v) that is a trust for the benefit of an individual Holder or such Holder’s Immediate Family Member, provided the Company is, within a reasonable time after such transfer, furnished with
written notice of the name and address of such transferee or assignee and the securities with respect to which such registration rights are being assigned; and provided, further, that such assignment shall be effective only if the transferee agrees
to be bound by this Agreement and immediately following such transfer the further disposition of such securities by the transferee or assignee is restricted under the Securities Act. Notwithstanding the foregoing, the limitation set forth in
subsection (i) hereto shall not apply with respect to the transfer of any Registrable Securities to W Capital Partners III, L.P. or any of its Affiliates (“W Capital”) or Montreux Equity Partners V, L.P. or any of its
Affiliates (“Montreux”) in connection with the Tender Offer (as defined in the Purchase Agreement) or pursuant to the Secondary Purchase Right of First Refusal or Alternative ROFR Rights (each as defined in the Amended and Restated
Right of First Refusal and Co-Sale Agreement, dated as of the date hereof); provided that the exclusion in this sentence shall not apply to any subsequent transfer by W Capital or Montreux. For the purposes of determining the number of shares of
Registrable Securities held by a transferee or assignee, the holdings of transferees and assignees of (x) a partnership who are partners or retired partners of such partnership or (y) a limited liability company who are members or retired
members of such limited liability company (including 

  
 -14- 

 
Immediate Family Members of such partners or members who acquire Registrable Securities by gift, will or intestate succession) shall be aggregated together and with the partnership or limited
liability company; provided that all assignees and transferees who would not qualify individually for assignment of registration rights shall have a single attorney-in-fact for the purpose of exercising any rights, receiving notices or taking any
action under Section 2. 
 2.13 Limitations on Subsequent Registration Rights. From and after the date of this Agreement,
the Company shall not, without the prior written consent of the Required Other Holders, the Required Series C Holders and the Required Series D, E, F and G Holders, enter into any agreement with any holder or prospective holder of any
securities of the Company which would allow such holder or prospective holder (a) to include such securities in any registration filed under Section 2.2, 2.3 or 2.4 hereof, unless under the terms of such agreement, such holder or
prospective holder may include such securities in any such registration only to the extent that the inclusion of his or its securities will not reduce the amount of the Registrable Securities of the Holders which is included or (b) to make a
demand registration which could result in such registration statement being declared effective prior to the earlier of either of the dates set forth in subsection 2.2(a) or within 120 days of the effective date of any registration effected
pursuant to Section 2.2. 
 2.14 Termination of Registration Rights. No Holder shall be entitled to exercise any right
provided for in this Section 2 after the termination of this Agreement, as provided in Section 4. 
 3. Covenants of the
Company. 
 3.1 Delivery of Financial Statements. The Company shall deliver to each Investor holding not less than
235,000 shares of Registrable Securities (as adjusted for stock splits, stock dividends or the like) (each, a “Major Investor”): 

(a) within 150 days after the end of each fiscal year of the Company, an income statement for such fiscal year, a balance sheet of the
Company and statement of shareholders’ equity as of the end of such year, and a statement of cash flows for such year, such year-end financial reports to be in reasonable detail, prepared in accordance with generally accepted accounting
principles (“GAAP”), and audited and certified by an independent public accounting firm of nationally recognized standing selected by the Company; 

(b) within 60 days after the end of each quarter of each fiscal year of the Company, an unaudited profit or loss statement, a statement of
cash flows for such fiscal quarter and an unaudited balance sheet as of the end of such fiscal quarter; 
 (c) within 45 days of the end of
each month (other than months ending at the end of a fiscal quarter), a monthly report detailing key financial and other metrics used to measure the Company’s performance and progress, substantially in the form of Exhibit A hereto; and

 (d) within 45 days prior to the end of each fiscal year, a budget for the next fiscal year, prepared on a monthly basis. 

  
 -15- 

 Notwithstanding anything else in this Section 3.1 to the contrary, the Company may cease providing the
information set forth in this Section 3.1 during the period starting with the date 60 days before the Company’s good-faith estimate of the date of filing of a registration statement only if it reasonably concludes it must do so to comply
with the SEC rules applicable to such registration statement and related offering; provided that the Company’s covenants under this Section 3.1 shall be reinstated at such time as the Company is no longer actively employing its
commercially reasonable efforts to cause such registration statement to become effective. 
 3.2 Annual Budget. The adoption
of the Company’s annual budget must be approved by the holders of at least a majority of the then outstanding shares of Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock
and Series G Preferred Stock (in each case, on an as-converted basis), voting together as a single class. 
 3.3
Inspection. The Company shall permit each Major Investor that is not a competitor of the Company, as determined by the Company’s Board of Directors (the “Board of Directors”) in good faith, at such Major
Investor’s expense, to visit and inspect the Company’s properties, to examine its books of account and records and to discuss the Company’s affairs, finances and accounts with its officers, all at such reasonable times as may be
requested by such Major Investor; provided, however, that the Company shall not be obligated pursuant to this Section 3.3 to provide access to any information which it reasonably considers to be privileged or a trade secret or similar
confidential information. The parties hereto agree that neither Catalyst nor BVP (each as defined below) shall be deemed a competitor of the Company for purposes of this Section 3.3. 

3.4 Right of First Offer. Subject to the terms and conditions specified in this Section 3.4, the Company hereby grants to
each Major Investor a right of first offer with respect to future sales by the Company of its Shares (as hereinafter defined). Each time the Company proposes to offer any shares of, or securities convertible into or exercisable for any shares of,
any class of its capital stock other than in connection with an Excluded Issuance (as defined in the Company’s Articles of Incorporation as in effect on the date hereof) (“Shares”), the Company shall first make an offering of
such Shares to each Major Investor in accordance with the following provisions: 
 (a) The Company shall deliver a notice (the “RFO
Notice”) to the Major Investors stating (i) its bona fide intention to offer such Shares, (ii) the number of such Shares to be offered, and (iii) the price and terms, if any, upon which it proposes to offer such Shares. 

(b) Within 10 calendar days after delivery of the RFO Notice, each Major Investor may elect to purchase or obtain, at the price and on the
terms specified in the RFO Notice, up to that portion of such Shares which equals the proportion that the number of shares of Common Stock issued and held, or issuable upon conversion and exercise of all convertible or exercisable securities then
held (other than any shares of Common Stock issuable to employees, consultants or directors pursuant to a stock option plan, restricted stock plan, or other stock plan), by such Major Investor bears to the total number of shares of Common Stock then
outstanding (assuming full conversion and exercise of all convertible or exercisable securities, other than any shares of Common Stock issuable to employees, consultants or 

  
 -16- 

 
directors pursuant to a stock option plan, restricted stock plan, or other stock plan). Such purchase shall be completed at the same closing as that of any third party purchasers or at an
additional closing thereunder. The Company shall promptly, in writing, inform each Major Investor that purchases all the Shares available to it (each, a “Fully-Exercising Investor”) of any other Major Investor’s failure to do
likewise. During the 5-day period commencing after receipt of such information, each Fully-Exercising Investor shall be entitled to obtain that portion of the Shares for which Major Investors were entitled to subscribe but which were not subscribed
for by the Major Investors that is equal to the proportion that the number of shares of Common Stock issued and held, or issuable upon conversion and exercise of all convertible or exercisable securities then held, by such Fully-Exercising Investor
bears to the total number of shares of Common Stock then outstanding (assuming full conversion and exercise of all vested convertible or exercisable securities) issued and held, or issuable upon conversion of the Preferred Stock then held, by all
Fully-Exercising Investors who elect to purchase such unsubscribed Shares. If Catalyst Investors QP II, L.P. or any of its Affiliates (“Catalyst”), Bessemer Venture Partners VII L.P. or any of its Affiliates
(“BVP”), Institutional Venture Partners XIII, L.P. or any of its Affiliates (“IVP”), W Capital or Montreux exercise their right to purchase Shares in accordance with this Section 3.4, the closing of the sale of such
Shares shall not occur any sooner than 14 business days after the expiration of the period provided in this subsection 3.4(b), unless Catalyst, BVP, IVP, W Capital or Montreux, as applicable, consents to a shorter period. 

(c) The Company may, during the 90-day period following the expiration of the period provided in subsection 3.4(b) hereof, offer the
remaining unsubscribed portion of the Shares to any person or persons at a price not less than, and upon terms no more favorable to the offeree than those, specified in the RFO Notice. If the Company does not enter into an agreement for the sale of
the Shares within such period, or if such agreement is not consummated within 90 days of the execution thereof, the right provided hereunder shall be deemed to be revived and such Shares shall not be offered unless first reoffered to the Major
Investors in accordance herewith. 
 (d) In addition to the foregoing, the right of first offer in this Section 3.4 shall not be
applicable with respect to any Major Investor if (i) at the time of such subsequent securities issuance, such Major Investor is not an “accredited investor,” as that term is then defined in Rule 501(a) under the Securities Act, and
(ii) the securities issuance is otherwise being offered only to accredited investors. 
 (e) Notwithstanding the foregoing, a Major
Investor’s right of first offer set forth in this Section 3.4 shall not be affected in any manner for any subsequent offering of Shares if such Major Investor fails to be a Fully-Exercising Investor with respect to any consummated offering
of Shares subject to this Section 3.4. 
 3.5 Confidentiality. Each Investor and each Founder shall keep confidential and
shall not disclose, divulge or use for any purpose (other than to monitor its investment in the Company) any confidential information obtained from the Company pursuant to the terms of this Agreement (including notice of the Company’s intention
to file a registration statement), unless such confidential information (a) is known or becomes known to the public in general (other than as a result of a breach of this Section 3.5 by such Investor or Founder, as applicable), (b) is
or has been independently developed or conceived by the Investor or Founder, as applicable, 

  
 -17- 

 
without use of the Company’s confidential information, or (c) is or has been made known or disclosed to the Investor or Founder, as applicable, by a third party without a breach of any
obligation of confidentiality such third party may have to the Company; provided, however, that an Investor or Founder, as applicable, may disclose confidential information (i) to its attorneys, accountants, consultants, and other professionals
to the extent necessary to obtain their services in connection with monitoring its investment in the Company; (ii) to any prospective purchaser of any Registrable Securities from such Investor or Founder, as applicable, if such prospective
purchaser agrees to be bound by the provisions of this Section 3.5; (iii) to any Affiliate, partner, member, stockholder, or wholly owned subsidiary of such Investor in the ordinary course of business, provided that such Investor informs
such person that such information is confidential and directs such person to maintain the confidentiality of such information; or (iv) as may otherwise be required by law, provided that the Investor or Founder, as applicable, promptly notifies
the Company of such disclosure and takes reasonable steps to minimize the extent of any such required disclosure. 
 3.6 Confidential
Information Agreement and Invention Assignment Agreement. The Company shall enter into the Company’s standard form of Confidential Information Agreement and the Company’s standard form of Invention Assignment Agreement previously
provided to the Investors and their respective counsel with each person hereafter employed by it (or engaged by the Company as a consultant or independent contractor) with access to confidential information and/or trade secrets. 

3.7 Stock Vesting. With respect to any restricted shares issued or options or rights granted, unless the Board of Directors
approves otherwise, the Company shall cause each officer, director, employee of or consultant to the Company (“Option or Restricted Stock Holder”) to enter into an agreement providing for (a) vesting of such shares or options
or rights over forty-eight (48) months and (b) such officer, director, employee, consultant, contractor or other service provider of the Company to become party to each of the Right of First Refusal and Co-Sale Agreement and the Voting
Agreement upon the granting of such shares or exercise of such options, as the case may be, and (c) acceleration upon a Sale of the Company as follows: 50% of the unvested shares shall accelerate and vest in full upon a Sale of the Company; and
the remaining 50% shall accelerate and vest in full in the event the option holder’s employment is terminated within 6 months following a Sale of the Company. “Sale of the Company” shall mean either: (i) a transaction or
series of related transactions in which a person or entity, or a group of related persons or entities acquires from shareholders of the Company shares representing more than 50% of the outstanding voting power of the Company; or (ii) a
transaction that qualifies as a “Liquidation Transaction” pursuant to the Restated Articles. 
 3.8 Investor Director
Approval. The Company shall not, without the approval of the Board of Directors (including the separate approvals of the Series C Director, the Series D Director and the Series F Director (as such terms are defined in the
Voting Agreement)), do any of the following: 
 (a) enter into or be a party to any transaction with (i) any director or officer of
the Company, (ii) any member of the Immediate Family of any director or officer of the Company, or (iii) an entity in which any director or officer of the Company or a member of the Immediate Family member of any director or officer of the
Company is a director, officer or, directly or indirectly, 5% equityholder; and 

  
 -18- 

 (b) hire, fire or change the compensation of the chief executive officer, chief operating
officer, treasurer, chief financial officer, chief technology officer or chief sales and marketing officer of the Company, including approving the adoption or amendment of any option grants or award compensation packages. 

3.9 Termination of Certain Covenants. 

(a) Each of the covenants set forth in this Section 3 (other than the covenants set forth in Sections 3.5 and 3.9) shall terminate as to
each Holder and be of no further force or effect (i) immediately prior to the consummation of a Qualifying IPO, or (ii) upon termination of this Agreement, as provided in Section 4. 

(b) The covenants set forth in Section 3.1 shall be suspended as to each Holder when the Company first becomes (and for so long as the
Company is) subject to the periodic reporting requirements of Sections 13 or 15(d) of the Exchange Act, if this occurs earlier than the events described in Section 3.9(a). 

4. Termination of Agreement. 

4.1 Termination Events. This Agreement shall terminate and have no further force or effect upon the earlier of: 

(a) the liquidation, dissolution or indefinite cessation of the business operations of the Company; or 

(b) the consummation of a transaction or series of related transactions that constitute a Liquidation Event (as defined in the Restated
Articles). 
 5. Miscellaneous. 

5.1 Entire Agreement. This Agreement constitutes the entire agreement between the parties hereto pertaining to the subject matter
hereof, and supersedes any and all other written or oral agreements relating to the subject matter hereof existing between the parties hereto. 

5.2 Successors and Assigns; Third Party Beneficiaries. Except as otherwise provided in this Agreement, the terms and conditions
of this Agreement shall inure to the benefit of and be binding upon the respective successors, assigns and legal representatives of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the
parties hereto or their respective successors, assigns and legal representatives any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement (including, without limitation,
in Section 2.10). 
 5.3 Amendments and Waivers. Any term of this Agreement may be amended or waived only with the
written consent of (a) the Company, (b) the Required Other 

  
 -19- 

 
Holders, and (c) the holders of not less than a majority of the of the outstanding shares of Series C Registrable Securities, Series D Registrable Securities, Series E
Registrable Securities, Series F Registrable Securities and Series G Registrable Securities (in each case, on an as-converted basis), voting together as a single class; provided, however, that if such amendment or waiver adversely affects
an Investor in a manner adversely and disproportionately as compared to other Investors, the affirmative vote or written consent of such Investor shall be required. Any amendment or waiver effected in accordance with this Section 5.3 shall be
binding upon the Company, the Founders, the Investors, and each of their respective successors and assigns. Notwithstanding the foregoing, additional holders of Common Stock shall become a party to this Agreement as a “Founder” hereunder,
without the need for any consent, approval or signature of any Shareholder hereunder, when such holder has executed one or more counterpart signature pages to this Agreement as a “Founder”, with the Company’s consent. 

5.4 Notices. Any notice required or permitted by this Agreement shall be in writing and shall be deemed sufficient on the date
of delivery, when delivered personally or by overnight courier or sent by fax or email (upon customary confirmation of receipt), or forty-eight (48) hours after being deposited in the U.S. mail, as certified or registered mail, with postage
prepaid, and addressed to the party to be notified at such party’s address or fax number as set forth below on the signature pages or on Schedule 1, Schedule 2, Schedule 3, Schedule 4,
Schedule 5, Schedule 6 or Schedule 7 hereto, or as subsequently modified by written notice. 
 5.5
Aggregation of Stock. All shares of capital stock of the Company held or acquired by Affiliated entities or persons shall be aggregated together for the purpose of determining the availability of any rights under this Agreement and
such Affiliated persons may apportion such rights as among themselves in any manner they deem appropriate. As used herein, “Affiliate” means, with respect to any specified Investor, any other Investor who, directly or indirectly,
controls, is controlled by or is under common control with such Investor, including, without limitation, any general partner, managing member, officer or director of such Investor, or any venture capital fund now or hereafter existing which is
controlled by one or more general partners or managing members of, or shares the same management company with, such Investor. 
 5.6
Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith to effectuate, to the greatest extent legally permissible, the
intent of such provision. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (a) such provision shall be excluded from this Agreement, (b) the balance of this Agreement
shall be interpreted as if such provision were so excluded and (c) the balance of this Agreement shall be enforceable in accordance with its terms. 

5.7 Governing Law. This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties
hereto shall be governed, construed and interpreted in accordance with the laws of the State of Delaware, without giving effect to principles of conflicts of law. 

5.8 Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original and all
of which together shall constitute one and the same instrument. 

  
 -20- 

 5.9 Titles and Subtitles. The titles and subtitles used in this Agreement are used
for convenience only and are not to be considered in construing or interpreting this Agreement. 
 [Signature Page Follows] 

  
 -21- 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of the
date first written above. 
  

									
	THE COMPANY:				THE FOUNDERS:
			
	MINDBODY, INC.				RICHARD L. STOLLMEYER VOTING TRUST
					
	By:		 /s/ Richard L. Stollmeyer
				 By:
		 /s/ Richard L. Stollmeyer

			(Signature)				 Name: 
		 Richard L. Stollmeyer

							 Title:
		 Trustee

	Richard L. Stollmeyer						
	Chief Executive Officer						
				
	 Address:
						
	 4051 Broad Street, Suite #220
						
	 San Luis Obispo, California 93401
						
	 Attn: Chief Executive Officer
						
	 Fax: 
						
	 Email:
						
			
	THE SERIES A AND B HOLDERS:				THE SERIES C HOLDERS:
			
	  
				  

	(PRINT NAME)				(PRINT NAME)
					
	By:		  
				By:		  

			(Signature)						(Signature)
					
	Name:		  
				Name:		  

					
	Title:		  
				Title:		  

  
 [Signature Page to
Amended and Restated Investors’ Rights Agreement] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of the
date first written above. 
  

									
	THE COMPANY:		 		THE FOUNDERS:
			
	MINDBODY, INC.				ROBERT MURPHY
					
	By:		  
				By:		 /s/ Robert Murphy

			(Signature)						(Signature)
				
	 Richard L. Stollmeyer

Chief Executive Officer
						
				
	 Address:
 4051 Broad Street, Suite
#220
 San Luis Obispo, California 93401
 Attn: Chief Executive
Officer
 Fax:
 Email:
						
			
	THE SERIES A AND B HOLDERS:				THE SERIES C HOLDERS:
			
	  
				  

	(PRINT NAME)				(PRINT NAME)
					
	By:		  
				By:		  

			(Signature)						(Signature)
					
	Name:		  
				Name:		  

					
	 Title:
		  
				Title:		  

  
 [Signature Page to
Amended and Restated Investors’ Rights Agreement] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of the
date first written above. 
  

									
	THE COMPANY:				THE FOUNDERS:
			
	MINDBODY, INC.				  

					(PRINT NAME)
				
	By:		  
				  

			(Signature)				(Signature)
				
	Richard L. Stollmeyer						
	Chief Executive Officer						
				
	Address:						
	4051 Broad Street, Suite #220						
	San Luis Obispo, California 93401						
	Attn: Chief Executive Officer						
	Fax:						
	Email:						
			
	THE SERIES A AND B HOLDERS:				THE SERIES C HOLDERS:
			
	CATALYST INVESTORS QP II, L.P.				CATALYST INVESTORS QP II, L.P.
	CATALYST INVESTORS II, L.P.				CATALYST INVESTORS II, L.P.
					
	By:		Catalyst Investors Partners II, L.P., their general partner				By:		Catalyst Investors Partners II, L.P., their general partner
	By:		Catalyst Investors Partners, L.L.C., its general partner				By:		Catalyst Investors Partners, L.L.C., its general partner
					
	By:		 /s/ Christopher J. Shipman
				By:		 /s/ Christopher J. Shipman

			(Signature)						(Signature)
	Name:		Christopher J. Shipman				Name: 		Christopher J. Shipman
	Title:		Executive Vice President				Title:		Executive Vice President

  
 [Signature Page to
Amended and Restated Investors’ Rights Agreement] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of the
date first written above. 
  

			
	THE SERIES D HOLDERS AND THE SERIES E HOLDERS:
	
	BESSEMER VENTURE PARTNERS VII L.P.
	BESSEMER VENTURE PARTNERS VII INSTITUTIONAL L.P.
	BVP VII SPECIAL OPPORTUNITY FUND L.P.
		
	By:		Deer VII & Co. L.P., their General Partner
	By:		Deer VII & Co. Ltd., its General Partner
		
	By:		 /s/ J. Edmund Colloton

			J. Edmund Colloton, Director
	
	CATALYST INVESTORS QP II, L.P.
	CATALYST INVESTORS II, L.P.
		
	By:		Catalyst Investors Partners II, L.P., their general partner
	By:		Catalyst Investors Partners, L.L.C., its general partner
		
	By:		  

			(Signature)
		
	Name:		  

		
	Title:		  

  
 [Signature Page to
Amended and Restated Investors’ Rights Agreement] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of the
date first written above. 
  

			
	THE SERIES D HOLDERS AND THE SERIES E HOLDERS:
	
	BESSEMER VENTURE PARTNERS VII L.P.
	BESSEMER VENTURE PARTNERS VII INSTITUTIONAL L.P.
	BVP VII SPECIAL OPPORTUNITY FUND L.P.
		
	By:		Deer VII & Co. L.P., their General Partner
	By:		Deer VII & Co. Ltd., its General Partner
		
	By:		  

			J. Edmund Colloton, Director
	
	CATALYST INVESTORS QP II, L.P.
	CATALYST INVESTORS II, L.P.
		
	By:		Catalyst Investors Partners II, L.P., their general partner
	By:		Catalyst Investors Partners, L.L.C., its general partner
		
	By:		 /s/ Christopher J. Shipman

			(Signature)
	Name:		Christopher J. Shipman
	Title:		Executive Vice President

  
 [Signature Page to
Amended and Restated Investors’ Rights Agreement] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of the
date first written above. 
  

			
	THE SERIES F HOLDERS:
	
	BESSEMER VENTURE PARTNERS VII L.P.
	BESSEMER VENTURE PARTNERS VII INSTITUTIONAL L.P.
	BVP VII SPECIAL OPPORTUNITY FUND L.P.
		
	By:		Deer VII & Co. L.P., their General Partner
	By:		Deer VII & Co. Ltd., its General Partner
		
	By:		 /s/ J. Edmund Colloton

			J. Edmund Colloton, Director
	
	CATALYST INVESTORS QP II, L.P.
	CATALYST INVESTORS II, L.P.
		
	By:		Catalyst Investors Partners II, L.P., their general partner
	By:		Catalyst Investors Partners, L.L.C., its general partner
		
	By:		  

	(Signature)
		
	Name:		  

		
	Title:		  

	
	INSTITUTIONAL VENTURE PARTNERS XIII, L.P.
		
	By:		Institutional Venture Management XIII, LLC,
			its General Partner
		
	By:		  

	(Signature)
		
	Name:		  

		
	Title:		  

  
 [Signature Page to
Amended and Restated Investors’ Rights Agreement] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of the
date first written above. 
  

			
	THE SERIES F HOLDERS:
	
	BESSEMER VENTURE PARTNERS VII L.P.
	BESSEMER VENTURE PARTNERS VII INSTITUTIONAL L.P.
	BVP VII SPECIAL OPPORTUNITY FUND L.P.
		
	By:		Deer VII & Co. L.P., their General Partner
	By:		Deer VII & Co. Ltd., its General Partner
		
	By:		  

			J. Edmund Colloton, Director
	
	CATALYST INVESTORS QP II, L.P.
	CATALYST INVESTORS II, L.P.
		
	By:		Catalyst Investors Partners II, L.P., their general partner
	By:		Catalyst Investors Partners, L.L.C., its general partner
		
	By:		 /s/ Christopher J. Shipman

	(Signature)
	Name:		Christopher J. Shipman
	Title:		Executive Vice President
	
	INSTITUTIONAL VENTURE PARTNERS XIII, L.P.
		
	By:		Institutional Venture Management XIII, LLC,
			its General Partner
		
	By:		  

	(Signature)
		
	Name:		  

		
	Title:		  

  
 [Signature Page to
Amended and Restated Investors’ Rights Agreement] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of the
date first written above. 
  

			
	THE SERIES F HOLDERS:
	
	BESSEMER VENTURE PARTNERS VII L.P.
	BESSEMER VENTURE PARTNERS VII INSTITUTIONAL L.P.
	BVP VII SPECIAL OPPORTUNITY FUND L.P.
		
	By:		Deer VII & Co. L.P., their General Partner
	By:		Deer VII & Co. Ltd., its General Partner
		
	By:		  

			J. Edmund Colloton, Director
	
	CATALYST INVESTORS QP II, L.P.
	CATALYST INVESTORS II, L.P.
		
	By:		Catalyst Investors Partners II, L.P., their general partner
	By:		Catalyst Investors Partners, L.L.C., its general partner
		
	By:		  

	(Signature)
		
	Name:		  

		
	Title:		  

	
	INSTITUTIONAL VENTURE PARTNERS XIII, L.P.
		
	By:		Institutional Venture Management XIII LLC
	Its:		General Partner
		
	By:		 /s/ Melanie Chladek

			CFO and Administrative Partner

			
		
	Address:		3000 Sand Hill Road
			Building 2, Suite 250
			Menlo Park, CA 94025

  
 [Signature Page to
Amended and Restated Investors’ Rights Agreement] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of the
date first written above. 
  

			
	THE NEW INVESTORS:
	
	W CAPITAL PARTNERS III, L.P.
		
	By:		WCP GP III, L.P., its General Partner
	By:		WCP GP III, LLC, its General Partner
		
	By:		 /s/ David Wachter

	Name:		David Wachter
	Title:		Managing Member
	
	MONTREUX EQUITY PARTNERS V, L.P.
		
	By:		Montreux Equity Management V, LLC,
			its General Partner
		
	By:		  

	(Signature)
		
	Name:		Daniel K. Turner III
	Title:		Managing Member

  
 [Signature Page to
Amended and Restated Investors’ Rights Agreement] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of the
date first written above. 
  

			
	THE NEW INVESTORS:
	
	W CAPITAL PARTNERS III, L.P.
		
	By:		WCP GP III, L.P., its General Partner
	By:		WCP GP III, LLC, its General Partner
		
	By:		  

	Name:		  

	Title:		  

	
	MONTREUX EQUITY PARTNERS V, L.P.
		
	By:		Montreux Equity Management V, LLC,
			its General Partner
		
	By:		 /s/ Daniel K. Turner III

	(Signature)
		
	Name:		Daniel K. Turner III
	Title:		Managing Member

  
 [Signature Page to
Amended and Restated Investors’ Rights Agreement] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of the
date first written above. 
  

			
	THE NEW INVESTORS:
	
	BESSEMER VENTURE PARTNERS VII L.P.
	BESSEMER VENTURE PARTNERS VII INSTITUTIONAL L.P.
	BVP VII SPECIAL OPPORTUNITY FUND L.P.
		
	By:		Deer VII & Co. L.P., their General Partner
	By:		Deer VII & Co. Ltd., its General Partner
		
	By:		 /s/ J. Edmund Colloton

			J. Edmund Colloton, Director
	
	CATALYST INVESTORS QP II, L.P.
	CATALYST INVESTORS II, L.P.
		
	By:		Catalyst Investors Partners II, L.P., their general partner
	By:		Catalyst Investors Partners, L.L.C., its general partner
		
	By:		  

			(Signature)
		
	Name:		  

	Title:		  

	
	Institutional Venture Partners XIII, L.P.
		
	By:		Institutional Venture Management XIII LLC
	Its:		General Partner
		
	By:		  

			Managing Director

			
		
	Address:  		3000 Sand Hill Road
			Building 2, Suite 250
			Menlo Park, CA 94025

  
 [Signature Page to
Amended and Restated Investors’ Rights Agreement] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of the
date first written above. 
  

			
	THE NEW INVESTORS:
	
	BESSEMER VENTURE PARTNERS VII L.P.
	BESSEMER VENTURE PARTNERS VII INSTITUTIONAL L.P.
	BVP VII SPECIAL OPPORTUNITY FUND L.P.
		
	By:		Deer VII & Co. L.P., their General Partner
	By:		Deer VII & Co. Ltd., its General Partner
		
	By:		  

			J. Edmund Colloton, Director
	
	CATALYST INVESTORS QP II, L.P.
	CATALYST INVESTORS II, L.P.
		
	By:		Catalyst Investors Partners II, L.P., their general partner
	By:		Catalyst Investors Partners, L.L.C., its general partner
		
	By:		 /s/ Christopher J. Shipman

			(Signature)
	Name:		Christopher J. Shipman
	Title:		Executive Vice President
	
	Institutional Venture Partners XIII, L.P.
		
	By:		Institutional Venture Management XIII LLC
	Its:		General Partner
		
	By:		  

			Managing Director

			
		
	Address:		             3000 Sand Hill Road
			             Building 2, Suite 250
			             Menlo Park, CA 94025

  
 [Signature Page to
Amended and Restated Investors’ Rights Agreement] 

 The parties have executed this Amended and Restated Investors’ Rights Agreement as of the
date first written above. 
  

			
	THE NEW INVESTORS:
	
	BESSEMER VENTURE PARTNERS VII L.P.
	BESSEMER VENTURE PARTNERS VII INSTITUTIONAL L.P.
	BVP VII SPECIAL OPPORTUNITY FUND L.P.
		
	By:		Deer VII & Co. L.P., their General Partner
	By:		Deer VII & Co. Ltd., its General Partner
		
	By:		  

			J. Edmund Colloton, Director
	
	CATALYST INVESTORS QP II, L.P.
	CATALYST INVESTORS II, L.P.
		
	By:		Catalyst Investors Partners II, L.P., their general partner
	By:		Catalyst Investors Partners, L.L.C., its general partner
		
	By:		  

	(Signature)
		
	Name:		  

	Title:		  

	
	Institutional Venture Partners XIII, L.P.
		
	By:		Institutional Venture Management XIII LLC
	Its:		General Partner
		
	By:		 /s/ Melanie Chladek

			CFO and Administrative Partner

			
		
	Address:		        3000 Sand Hill Road
			        Building 2, Suite 250
			        Menlo Park, CA 94025

  
 [Signature Page to
Amended and Restated Investors’ Rights Agreement] 

 SCHEDULE 1 

FOUNDERS 
  

	
	 Name

	Robert Murphy
	
	Richard L. Stollmeyer Voting Trust

 SCHEDULE 2 

SERIES A AND B HOLDERS 
  

	
	 Name

	David N. Bernstein
	
	Eric & Irina Meyer
	
	Nicholas H. Stonnington
	
	Daryl Bernstein
	
	Jacques & Regine Meyer
	
	Barry Paulk
	
	Gerda D. Levy
	
	William H. Slattery
	
	James N. Adler
	
	John Bell
	
	James S. Bennett, Bennett Family Trust
	
	Boris Droutman
	
	Craig & Katherine Francis
	
	Bob Frazee
	
	S. Robert Frazee
	
	Steven Gabor, King Trust, Steven Cabor, Successor Trustee
	
	Adam Guttentag
	
	Boris Koropey
	
	Kenneth Ramberg, The Tower Trust, Kenneth Ramberg Trustee
	
	Michael P. Ridley

	
	 Name

	
	 William Rothbard, William Rothbard Inter Vivos Trust

	
	 Daniel A. Seigel, The Daniel and Elaine Seigel Revocable Trust

	
	 Richard J. Slater, TTEE, The Slater Family Trust

	
	 Alison Sweeney

	
	 Ryan M. Sweeney Irrevocable Trust

	
	 Stender E. Sweeney

	
	 Douglas Swets, Swets Family Trust

	
	 H. Andrew Thornburg, Thornburg & Co., Inc. Retirement Trust

	
	 William N. Tifft

	
	 Lead Edge Partners Opportunity I, LLC

	
	 EAPE Holdings, LLC

	
	 EAPEQ Holdings, LLC

	
	 Catalyst Investors II, L.P.

	
	 Catalyst Investors QP II, L.P.

  
 -2- 

 SCHEDULE 3 

SERIES C HOLDERS 
  

	
	 Name

	 Catalyst Investors II, L.P.
  

with a copy (which shall not constitute notice) to:

	
	Lowenstein Sandler LLP
	
	 Catalyst Investors QP II, L.P.
  

with a copy (which shall not constitute notice) to:

	
	Lowenstein Sandler LLP

 SCHEDULE 4 

SERIES D HOLDERS 
  

	
	 Name

	Bessemer Venture Partners VII L.P.
	
	With a copy (which shall not constitute notice) to:
	
	King & Spalding LLP
	
	Bessemer Venture Partners VII Institutional L.P.
	
	With a copy (which shall not constitute notice) to:
	
	King & Spalding LLP
	
	BVP VII Special Opportunity Fund L.P.
	
	With a copy (which shall not constitute notice) to:
	
	King & Spalding LLP
	
	Catalyst Investors II, L.P.
	
	 with a copy (which shall not constitute notice) to:

	
	Lowenstein Sandler LLP
	
	Catalyst Investors QP II, L.P.
	
	 with a copy (which shall not constitute notice) to:

	
	Lowenstein Sandler LLP

 SCHEDULE 5 

SERIES E HOLDERS 
  

	
	 Name

	Bessemer Venture Partners VII L.P.
	
	With a copy (which shall not constitute notice) to:
	
	King & Spalding LLP
	
	Bessemer Venture Partners VII Institutional L.P.
	
	With a copy (which shall not constitute notice) to:
	
	King & Spalding LLP
	
	BVP VII Special Opportunity Fund L.P.
	
	With a copy (which shall not constitute notice) to:
	
	King & Spalding LLP
	
	Catalyst Investors II, L.P.
	
	 with a copy (which shall not constitute notice) to:

	
	Lowenstein Sandler LLP
	
	Catalyst Investors QP II, L.P.
	
	with a copy (which shall not constitute notice) to:
	
	Lowenstein Sandler LLP

 SCHEDULE 6 

SERIES F HOLDERS 
  

	
	 Name

	 Bessemer Venture Partners VII L.P.

	
	 With a copy (which shall not constitute notice) to:

	
	 King & Spalding LLP

	
	 Bessemer Venture Partners VII Institutional L.P.

	
	 With a copy (which shall not constitute notice) to:

	
	 King & Spalding LLP

	
	 BVP VII Special Opportunity Fund L.P.

	
	 With a copy (which shall not constitute notice) to:

	
	 King & Spalding LLP

	
	 Catalyst Investors II, L.P.
  

with a copy (which shall not constitute notice) to:

	
	 Lowenstein Sandler LLP

	
	 Catalyst Investors QP II, L.P.

 
 with a copy (which shall not constitute notice)
to:

	
	 Lowenstein Sandler LLP

	
	 Institutional Venture Partners XIII, L.P.

 SCHEDULE 7 

NEW INVESTORS 
  

	
	 Name

	W Capital Partners III, L.P.
	
	 with a copy (which shall not constitute notice) to:

	
	Goodwin Procter LLP
	
	Montreux Equity Partners V, L.P.
	
	 with a copy (which shall not constitute notice) to:

	
	Fenwick & West LLP
	
	Bessemer Venture Partners VII L.P.
	
	With a copy (which shall not constitute notice) to:
	
	King & Spalding LLP
	
	Bessemer Venture Partners VII Institutional L.P.
	
	With a copy (which shall not constitute notice) to:
	
	King & Spalding LLP
	
	BVP VII Special Opportunity Fund L.P.
	
	With a copy (which shall not constitute notice) to:
	
	King & Spalding LLP
	
	Catalyst Investors II, L.P.
	
	 with a copy (which shall not constitute notice) to:

	
	Lowenstein Sandler LLP
	
	Catalyst Investors QP II, L.P.
	
	 with a copy (which shall not constitute notice) to:

	
	Lowenstein Sandler LLP
	
	Institutional Venture Partners XIII, L.P.

 Exhibit A 

[Monthly Snapshot Report] 

 EXECUTION COPY 

MINDBODY, INC. 

FIRST AMENDMENT TO THE 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

This First Amendment (this “Amendment”), entered into and effective as of March 25, 2014, is made to that certain
Amended and Restated Investors’ Rights Agreement (the “A&R IRA”) is made and entered into as of February 10, 2014, by and among Mindbody, Inc., a California corporation (the “Company”), the holders of
outstanding Common Stock of the Company listed on Schedule 1 thereto (the “Founders”), the holders of outstanding Series A Preferred Stock and Series B Preferred Stock of the Company listed on Schedule 2
thereto (the “Series A and B Holders”), the holders of outstanding Series C Preferred Stock of the Company listed on Schedule 3 thereto (the “Series C Holders”), the holders of outstanding
Series D Preferred Stock of the Company, listed on Schedule 4 thereto (the “Series D Holders”), the holders of Series E Preferred Stock of the Company listed on Schedule 5 thereto (the “Series E
Holders”), the holders of Series F Preferred Stock of the Company listed on Schedule 6 thereto (the “Series F Holders”) and the purchasers of Series G Preferred Stock of the Company listed on
Schedule 7 thereto (the “New Investors” and, together with the Series A and B Holders, the Series C Holders, the Series D Holders, the Series E Holders and the Series F Holders, the
“Investors”). All capitalized terms used herein and not otherwise defined shall have the meanings assigned to them in the A&R IRA. 

RECITALS 

WHEREAS, W Capital Partners III, L.P. (“W Capital”) and Montreux Equity Partners V, L.P. (“Montreux”)
have undertaken a tender offer (the “Tender Offer”) to purchase certain of the shares of the Company’s capital stock (the “Tender Offer Shares”), including shares currently held by the Founders, the
Series A and B Holders and the Common Holders, as described in that certain Side Letter Agreement (the “Side Letter”) dated as of February 10, 2014 between the Company, W Capital and Montreux; 

WHEREAS, the number of Tender Offer Shares submitted by eligible participants in the Tender Offer exceeded the maximum number of Tender
Offer Shares originally specified in the Side Letter (such excess Tender Offer Shares, the “Oversubscribed Shares”); 

WHEREAS, W Capital and Montreux desire to purchase all of the Tender Offer Shares submitted by eligible participants in the Tender
Offer, including the Oversubscribed Shares; 
 WHEREAS, the terms of the A&R IRA may be amended only with the written consent of
(collectively, the “Requisite Parties”): (a) the Company, (b) the Required Other Holders, and (c) the holders of not less than a majority of the of the outstanding shares of Series C Registrable Securities,
Series D Registrable Securities, Series E Registrable Securities, Series F Registrable Securities and Series G Registrable Securities (in each case, on an as-converted basis), voting together as a single class; and 

 EXECUTION COPY 

WHEREAS, in connection with W Capital’s and Montreux’s purchase of the Tender Offer Shares, including the Oversubscribed
Shares, each of the undersigned, which comprise the Requisite Parties, desire to amend the A&R IRA as set forth herein. 
 NOW,
THEREFORE, in exchange for good and valuable consideration including, without limitation, the mutual covenants contained herein, the sufficiency of which are hereby acknowledged, and intending to be legally bound here, the Requisite Parties
hereby agree as follows: 
 1) Amendment. In lieu of the reference to the Purchase Agreement, the term “Tender Offer,” as
used in Section 2.12 of the A&R IRA, shall mean the following: 
 “W Capital Partners III, L.P.’s (“W
Capital”) and Montreux Equity Partners V, L.P.’s (“Montreux”) offer to purchase up to $15,687,792 of shares from the holders of Common Stock, Series A Preferred Stock and Series B Preferred Stock of the Company on the
terms set forth in the (i) Side Letter Agreement, dated as of February 10, 2014, by and among the Company, W Capital and Montreux and (ii) Additional Side Agreement, dated as of March 25, 2014, by and among the Company, W Capital
and Montreux.” 
 2) Miscellaneous. 

a. Except as specifically amended hereby, the, terms and provisions of the A&R IRA shall continue in full force and effect. No reference to
this Amendment need to be made in any instrument or document making reference to the A&R IRA; any reference to the A&R IRA in any such instrument or document shall be deemed a reference to the A&R, IRA as amended hereby. The A&R IRA
as amended hereby shall be binding upon the parties thereto and their respective assigns and successors. 
 b. This Amendment may be
executed in two or more counterparts, each of which shall be deemed to be an original, but all of which together shall constitute one and the same instrument. 

c. This Amendment and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed,
construed and interpreted in accordance with the laws of the State of Delaware, without giving effect to principles of conflicts of law. 

[Signature Page Follows] 

  
 -2- 

 The parties have executed this Amendment to Amended and Restated Investors’ Rights Agreement
as of the date first written above. 
  

			
	THE COMPANY:
	
	MINDBODY, INC.
		
	By:		 /s/ Richard L. Stollmeyer

			Richard L. Stollmeyer
			Chief Executive Officer
		
	Address:		
	4051 Broad Street, Suite #220
	San Luis Obispo, California 93401
	Attn: Chief Executive Officer
	Fax:
	Email:
	
	FOUNDERS:
	
	RICHARD L. STOLLMEYER VOTING TRUST
		
	By:		 /s/ Richard Stollmeyer

	Name:		Richard L. Stollmeyer
	Title:		Trustee
	
	ROBERT MURPHY
	
	 /s/ Robert Murphy

	(Signature)

  
 [Signature Page to
Amended and Restated Investors’ Rights Agreement] 

 The parties have executed this Amendment to Amended and Restated Investors’ Rights Agreement
as of the date first written above. 
  

					
	INVESTORS:	 	 
		
	 	 	BESSEMER VENTURE PARTNERS VII L.P.
	 	 	BESSEMER VENTURE PARTNERS VII INSTITUTIONAL L.P.
	 	 	BVP VII SPECIAL OPPORTUNITY FUND L.P.
			
		 	By:	 	Deer VII & Co. L.P., their General Partner
		 	By:	 	Deer VII & Co. Ltd., its General Partner
			
		 	By: 	 	 /s/ J. Edmund Colloton

		 		 	J. Edmund Colloton, Director

  
 [Signature Page to
Amended and Restated Investors’ Rights Agreement] 

 The parties have executed this Amendment to Amended and Restated Investors’ Rights Agreement
as of the date first written above. 
  

			
	INVESTORS:
	
	Institutional Venture Partners XIII, L.P.
		
	By:		Institutional Venture Management XIII LLC
	Its:		General Partner
		
	By:		 /s/                
General Partner

			CFO and Administrative Partner
	
	Address: 3000 Sand Hill Road
	Building 2, Suite 250
	Menlo Park, CA 94025

  
 [Signature Page to
Amended and Restated Investors’ Rights Agreement] 

 The parties have executed this Amendment to Amended and Restated Investors’ Rights Agreement
as of the date first written above. 
  

			
	INVESTORS:
	
	CATALYST INVESTORS QP II, LP.
	CATALYST INVESTORS II, L.P.
		
	By:		Catalyst Investors Partners II, L.P., their general partner
	By:		Catalyst Investors Partners, L.L.C.; its general partner
		
	By:  		 /s/ Tyler Newton

	Name:  		Tyler Newton
	Title:  		Authorized Signatory

  
 [Signature Page to
Amended and Restated Investors’ Rights Agreement] 

 The parties have executed this Amendment to Amended and Restated Investors’ Rights Agreement
as of the date first written above. 
  

			
	INVESTORS:
	
	MONTREUX EQUITY PARTNERS V, L.P.
		
	By:		Montreux Equity Management V, LLC,
			its General Partner
		
	By:		 /s/ Daniel K. Turner III

	(Signature)
		
	Name		Daniel K. Turner III
	Title:		Managing Member

  
 [Signature Page to
Amended and Restated Investors’ Rights Agreement] 

 The parties have executed this Amendment to Amended and Restated Investors’ Rights Agreement
as of the date first written above. 
  

			
	INVESTORS:
	
	W CAPITAL PARTNERS III, L.P.
		
	By:		WCP GP III, L.P., its General Partner
	By:		WCP GP III, LLC, its General Partner
		
	By:		 /s/ David Wachter

	Name:		David Wachter
	Title:		Managing Member

  
 [Signature Page to
Amended and Restated Investors’ Rights Agreement]EX-10.4

 Exhibit 10.4 

MINDBODY, INC. 
 2009
STOCK OPTION PLAN 
 1. Purposes of the Plan. The purposes of this 2009 Stock Option Plan are to attract and retain
the best available personnel for positions of substantial responsibility, to provide additional incentive to Employees and Consultants, and to promote the success of the Company’s business. Options granted under the Plan may be Incentive Stock
Options or Nonstatutory Stock Options, as determined by the Administrator at the time of grant of an Option and subject to the applicable provisions of Section 422 of the Code and the regulations promulgated thereunder. Restricted Stock may
also be granted under the Plan. 
 2. Definitions. As used herein, the following definitions shall apply: 

(a) “Administrator” means the Board or a Committee. 

(b) “Affiliate” means an entity other than a Subsidiary which, together with the Company, is under common control of a
third person or entity. 
 (c) “Applicable Laws” means all applicable laws, rules, regulations and
requirements, including, but not limited to, all applicable U.S. federal or state laws, any Stock Exchange rules or regulations, and the applicable laws, rules or regulations of any other country or jurisdiction where Options or Restricted Stock are
granted under the Plan or Participants reside or provide services, as such laws, rules, and regulations shall be in effect from time to time. 

(d) “Award” means any award of an Option or Restricted Stock under the Plan. 

(e) “Board” means the Board of Directors of the Company. 

(f) “Business Entity” means any corporation, limited liability company, partnership, limited partnership or
other business entity. 
 (g) “California Participant” means a Participant whose Award is issued in reliance
on Section 25102(o) of the California Corporations Code. 
 (h) “Cashless Exercise” means a program
approved by the Administrator in which payment of the Option exercise price or tax withholding obligations may be satisfied, in whole or in part, with Shares subject to the Option, including by delivery of an irrevocable direction to a securities
broker (on a form prescribed by the Administrator) to sell Shares and to deliver all or part of the sale proceeds to the Company in payment of the aggregate exercise price and, if applicable, the amount necessary to satisfy the Company’s
withholding obligations. 
 (i) “Cause” for termination of a Participant’s Continuous Service Status will exist
(unless another definition is provided in an applicable Option Agreement, Restricted Stock Purchase Agreement, employment agreement or other applicable written agreement) if the Participant’s Continuous Service Status is terminated for any of
the following reasons: (i) Participant’s willful failure to perform his or her duties and responsibilities to the Company or Participant’s violation of any written Company policy; (ii) Participant’s commission of any act of
fraud, embezzlement, dishonesty or any other willful misconduct that has caused or is reasonably expected to result in injury to the Company; (iii) Participant’s unauthorized use or disclosure of any proprietary information or trade
secrets of the Company or any other party to whom 

 
the Participant owes an obligation of nondisclosure as a result of his or her relationship with the Company; or (iv) Participant’s material breach of any of his or her obligations under
any written agreement or covenant with the Company. The determination as to whether a Participant’s Continuous Service Status has been terminated for Cause shall be made in good faith by the Company and shall be final and binding on the
Participant. The foregoing definition does not in any way limit the Company’s ability to terminate a Participant’s employment or consulting relationship at any time, and the term “Company” will be interpreted to include any
Subsidiary, Parent, Affiliate, or any successor thereto, if appropriate. 
 (j) “Code” means the Internal Revenue
Code of 1986, as amended. 
 (k) “Committee” means one or more committees or subcommittees of the Board consisting
of two (2) or more Directors (or such lesser or greater number of Directors as shall constitute the minimum number permitted by Applicable Laws to establish a committee or sub-committee of the Board) appointed by the Board to administer the
Plan in accordance with Section 4 below. 
 (l) “Common Stock” means the Company’s common stock,
par value $0.001 per share, as adjusted in accordance with Section 14 below. 
 (m) “Company” means Mindbody,
Inc., a California corporation. 
 (n) “Consultant” means any person, including an advisor but not an Employee, who
is engaged by the Company, or any Parent, Subsidiary or Affiliate, to render services (other than capital-raising services) and is compensated for such services, and any Director whether compensated for such services or not. 

(o) “Continuous Service Status” means the absence of any interruption or termination of service as an
Employee or Consultant. Continuous Service Status as an Employee or Consultant shall not be considered interrupted or terminated in the case of: (i) Company approved sick leave; (ii) military leave; or (iii) any other bona fide leave
of absence approved by the Administrator, provided that such leave is for a period of not more than ninety (90) days, unless reemployment upon the expiration of such leave is guaranteed by contract or statute, or unless provided otherwise
pursuant to a written Company policy. Also, Continuous Service Status as an Employee or Consultant shall not be considered interrupted or terminated in the case of a transfer between locations of the Company or between the Company, its Parents,
Subsidiaries or Affiliates, or their respective successors, or a change in status from an Employee to a Consultant or from a Consultant to an Employee. 

(p) “Director” means a member of the Board. 

(q) “Disability” means “disability” within the meaning of Section 22(e)(3) of the Code. 

(r) “Employee” means any person employed by the Company, or any Parent, Subsidiary or Affiliate, with the status of
employment determined pursuant to such factors as are deemed appropriate by the Administrator in its sole discretion, subject to any requirements of the Applicable Laws, including the Code. The payment by the Company of a director’s fee shall
not be sufficient to constitute “employment” of such director by the Company or any Parent, Subsidiary or Affiliate. 
 (s)
“Exchange Act” means the Securities Exchange Act of 1934, as amended. 
 (t) “Fair
Market Value” means, as of any date, the per share fair market value of the Common Stock, as determined by the Administrator in good faith on such basis as it deems appropriate and

  
 -2- 

 
applied consistently with respect to Participants. Whenever possible, the determination of Fair Market Value shall be based upon the per share closing price for the Shares as reported in the
Wall Street Journal for the applicable date. 
 (u) “Family Members” means any child, stepchild,
grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law (including adoptive relationships) of the Optionee, any person
sharing the Optionee’s household (other than a tenant or employee), a trust in which these persons (or the Optionee) have more than 50% of the beneficial interest, a foundation in which these persons (or the Optionee) control the management of
assets, and any other entity in which these persons (or the Optionee) own more than 50% of the voting interests. 
 (v)
“Incentive Stock Option” means an Option intended to qualify as an incentive stock option within the meaning of Section 422 of the Code, as designated in the applicable Option Agreement. 

(w) “Listed Security” means any security of the Company that is listed or approved for listing on a national
securities exchange or designated or approved for designation as a national market system security on an interdealer quotation system by the National Association of Securities Dealers, Inc. qualify as an Incentive Stock Option, as designated in the
applicable Option Agreement. 
 (x) “Nonstatutory Stock Option” means an Option not intended to qualify as an
Incentive Stock Option, as designated in the applicable Option Agreement. 
 (y) “Option” means a stock option
granted pursuant to the Plan. 
 (z) “Option Agreement” means a written document, the form(s) of which shall be
approved from time to time by the Administrator, reflecting the terms of an Option granted under the Plan and includes any documents attached to or incorporated into such Option Agreement, including, but not limited to, a notice of stock option
grant and a form of exercise notice. 
 (aa) “Option Exchange Program” means a program approved by the
Administrator whereby outstanding Options (i) are exchanged for Options with a lower exercise price or Restricted Stock or (ii) are amended to decrease the exercise price as a result of a decline in the Fair Market Value of the Common
Stock. 
 (bb) “Optioned Stock” means Shares that are subject to an Option or that were issued pursuant to
the exercise of an Option. 
 (cc) “Optionee” means an Employee or Consultant who receives an Option. 

(dd) “Parent” means any Business Entity (other than the Company) in an unbroken chain of Business Entities ending with
the Company if, at the time of grant of the Award, each of the Business Entities other than the Company owns stock or other equity, membership or partnership interests possessing 50% or more of the total combined voting power of all classes of stock
or other equity, membership or partnership interests in one of the other Business Entities in such chain. A Business Entity that attains the status of a Parent on a date after the adoption of the Plan shall be considered a Parent commencing as of
such date. 
 (ee) “Participant” means any holder of one or more Awards or Shares issued pursuant to an Award. 

  
 -3- 

 (ff) “Plan” means this 2009 Stock Option Plan. 

(gg) “Restricted Stock” means Shares acquired pursuant to a right to purchase Common Stock granted pursuant to
Section 11 below. 
 (hh) “Restricted Stock Purchase Agreement” means a written document, the form(s) of which
shall be approved from time to time by the Administrator, reflecting the terms of Restricted Stock granted under the Plan and includes any documents attached to such agreement. 

(ii) “Rule 16b-3” means Rule 16b-3 promulgated under the Exchange Act, as amended from time to time, or any successor
provision. 
 (jj) “Share” means a share of Common Stock, as adjusted in accordance with Section 14 below. 

(kk) “Stock Exchange” means any stock exchange or consolidated stock price reporting system on which prices for the
Common Stock are quoted at any given time. 
 (ll) “Subsidiary” means any Business Entity (other than the Company)
in an unbroken chain of Business Entities beginning with the Company if, at the time of grant of the Award, each of the Business Entities other than the last Business Entity in the unbroken chain owns stock or other equity, membership or partnership
interests possessing 50% or more of the total combined voting power of all classes of stock or other equity, membership or partnership interests in one of the other Business Entities in such chain. A Business Entity that attains the status of a
Subsidiary on a date after the adoption of the Plan shall be considered a Subsidiary commencing as of such date. 
 (mm) “Ten
Percent Holder” means a person who owns stock representing more than 10% of the voting power of all classes of stock of the Company or any Parent or Subsidiary measured as of an Award’s date of grant. 

(nn) “Triggering Event” means: 

(i) a sale, transfer or disposition of all or substantially all of the Company’s assets other than to (A) a corporation or other
entity of which at least a majority of its combined voting power is owned directly or indirectly by the Company, (B) a corporation or other entity owned directly or indirectly by the holders of capital stock of the Company in substantially the
same proportions as their ownership of Common Stock, or (C) an Excluded Entity (as defined in subsection (ii) below); or 
 (ii)
any merger, consolidation or other business combination transaction of the Company with or into another corporation, entity or person, other than a transaction with or into another corporation, entity or person in which the holders of at least a
majority of the shares of voting capital stock of the Company outstanding immediately prior to such transaction continue to hold (either by such shares remaining outstanding in the continuing entity or by their being converted into shares of voting
capital stock of the surviving entity) a majority of the total voting power represented by the shares of voting capital stock of the Company (or the surviving entity) outstanding immediately after such transaction (an “Excluded
Entity”). 
 Notwithstanding anything stated herein, a transaction shall not constitute a “Triggering Event” if its sole
purpose is to change the state of the Company’s incorporation, or to create a holding company that will be owned in substantially the same proportions by the persons who hold the Company’s securities immediately before such transaction.
For clarity, the term “Triggering Event” as defined herein shall not include stock sale transactions whether by the Company or by the holders of capital stock. 

  
 -4- 

 3. Stock Subject to the Plan. Subject to the provisions of Section 14 of the
Plan, the maximum aggregate number of Shares that may be issued under the Plan is 1,986,979 Shares, of which a maximum of 1,986,979 Shares may be issued under the Plan pursuant to Incentive Stock Options. The Shares issued under the Plan may be
authorized, but unissued, or reacquired Shares. If an Award should expire or become unexercisable for any reason without having been exercised in full, or is surrendered pursuant to an Option Exchange Program, the unpurchased Shares that were
subject thereto shall, unless the Plan shall have been terminated, become available for future grant under the Plan. In addition, any Shares which are retained by the Company upon exercise of an Award in order to satisfy the exercise or purchase
price for such Award or any withholding taxes due with respect to such Award shall be treated as not issued and shall continue to be available under the Plan. Shares issued under the Plan and later repurchased by the Company pursuant to any
repurchase right that the Company may have shall not be available for future grant under the Plan. 
 4. Administration of the
Plan. 
 (a) General. The Plan shall be administered by the Board or a Committee, or a combination thereof, as
determined by the Board. The Plan may be administered by different administrative bodies with respect to different classes of Participants and, if permitted by Applicable Laws, the Board may authorize one or more officers of the Company to make
Awards under the Plan to Employees and Consultants (who are not subject to Section 16 of the Exchange Act) within parameters specified by the Board. 

(b) Committee Composition. If a Committee has been appointed pursuant to this Section 4, such Committee shall continue to
serve in its designated capacity until otherwise directed by the Board. From time to time the Board may increase the size of any Committee and appoint additional members thereof, remove members (with or without cause) and appoint new members in
substitution therefor, fill vacancies (however caused) and dissolve a Committee and thereafter directly administer the Plan, all to the extent permitted by the Applicable Laws and, in the case of a Committee administering the Plan in accordance with
the requirements of Rule 16b-3 or Section 162(m) of the Code, to the extent permitted or required by such provisions. 
 (c)
Powers of the Administrator. Subject to the provisions of the Plan and, in the case of a Committee, the specific duties delegated by the Board to such Committee, the Administrator shall have the authority, in its sole discretion: 

(i) to determine the Fair Market Value of the Common Stock in accordance with Section 2(t) above, provided that such determination shall
be applied consistently with respect to Participants under the Plan; 
 (ii) to select the Employees and Consultants to whom Awards may
from time to time be granted; 
 (iii) to determine the number of Shares to be covered by each Award; 

(iv) to approve the form(s) of agreement(s) and other related documents used under the Plan; 

(v) to determine the terms and conditions, not inconsistent with the terms of the Plan, of any Award granted hereunder, which terms and
conditions include but are not limited to the exercise 

  
 -5- 

 
or purchase price, the time or times when Awards may be exercised (which may be based on performance criteria), the circumstances (if any) when vesting will be accelerated or forfeiture
restrictions will be waived, and any restriction or limitation regarding any Award, Optioned Stock, or Restricted Stock; 
 (vi) to amend
any outstanding Award or agreement related to any Optioned Stock or Restricted Stock, including any amendment adjusting vesting (e.g., in connection with a change in the terms or conditions under which such person is providing services to the
Company), provided that no amendment shall be made that would materially and adversely affect the rights of any Participant without his or her consent; 

(vii) to determine whether and under what circumstances an Option may be settled in cash under Section 10(c) instead of Common Stock;

 (viii) to implement an Option Exchange Program and establish the terms and conditions of such Option Exchange Program, provided that no
amendment or adjustment to an Option that would materially and adversely affect the rights of any Optionee shall be made without his or her consent; 

(ix) to grant Awards to, or to modify the terms of any outstanding Option Agreement or Restricted Stock Purchase Agreement or any agreement
related to any Optioned Stock or Restricted Stock held by, Participants who are foreign nationals or employed outside of the United States with such terms and conditions as the Administrator deems necessary or appropriate to accommodate differences
in local law, tax policy or custom which deviate from the terms and conditions set forth in this Plan to the extent necessary or appropriate to accommodate such differences; and 

(x) to construe and interpret the terms of the Plan, any Option Agreement or Restricted Stock Purchase Agreement, and any agreement related
to any Optioned Stock or Restricted Stock, which constructions, interpretations and decisions shall be final and binding on all Participants. 

(d) Indemnification. To the maximum extent permitted by Applicable Laws, each member of the Committee (including officers of the
Company, if applicable), or of the Board, as applicable, shall be indemnified and held harmless by the Company against and from (i) any loss, cost, liability, or expense that may be imposed upon or reasonably incurred by him or her in
connection with or resulting from any claim, action, suit, or proceeding to which he or she may be a party or in which he or she may be involved by reason of any action taken or failure to act under the Plan or pursuant to the terms and conditions
of any Award except for actions taken in bad faith or failures to act in bad faith, and (ii) any and all amounts paid by him or her in settlement thereof, with the Company’s approval, or paid by him or her in satisfaction of any judgment
in any such claim, action, suit, or proceeding against him or her, provided that such member shall give the Company an opportunity, at its own expense, to handle and defend any such claim, action, suit or proceeding before he or she undertakes to
handle and defend it on his or her own behalf. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such persons may be entitled under the Company’s Articles of Incorporation, Certificate
of Incorporation or Bylaws, by contract, as a matter of law, or otherwise, or under any other power that the Company may have to indemnify or hold harmless each such person. 

5. Eligibility. 

(a) Recipients of Grants. Nonstatutory Stock Options and Restricted Stock may be granted to Employees and Consultants. Incentive
Stock Options may be granted only to Employees, provided that Employees of Affiliates shall not be eligible to receive Incentive Stock Options. 

  
 -6- 

 (b) Type of Option. Each Option shall be designated in the Option Agreement as
either an Incentive Stock Option or a Nonstatutory Stock Option. 
 (c) ISO $100,000 Limitation. Notwithstanding any
designation under Section 5(b), to the extent that the aggregate Fair Market Value of Shares with respect to which Options designated as Incentive Stock Options are exercisable for the first time by any Optionee during any calendar year (under
all plans of the Company or any Parent or Subsidiary) exceeds $100,000, such excess Options shall be treated as Nonstatutory Stock Options. For purposes of this Section 5(c), Incentive Stock Options shall be taken into account in the order in
which they were granted, and the Fair Market Value of the Shares subject to an Incentive Stock Option shall be determined as of the date of the grant of such Option. 

(d) No Employment Rights. Neither the Plan nor any Award shall confer upon any Employee or Consultant any right with respect to
continuation of an employment or consulting relationship with the Company (or with any Parent, Affiliate or Subsidiary), nor shall it interfere in any way with such Employee’s or Consultant’s right or the Company’s (or Parent’s,
Affiliate’s or Subsidiary’s) right to terminate his or her employment or consulting relationship at any time, with or without cause. 

6. Term of Plan. The Plan shall become effective upon its adoption by the Board of Directors. It shall continue in effect for a
term of ten (10) years unless sooner terminated under Section 16 below. 
 7. Term of Option. The term of each
Option shall be the term stated in the Option Agreement; provided that the term shall be no more than ten (10) years from the date of grant thereof or such shorter term as may be provided in the Option Agreement and provided further that, in
the case of an Incentive Stock Option granted to a person who at the time of such grant is a Ten Percent Holder, the term of the Option shall be five (5) years from the date of grant thereof or such shorter term as may be provided in the Option
Agreement. 
 8. [Reserved]. 

9. Option Exercise Price and Consideration. 

(a) Exercise Price. The per Share exercise price for the Shares to be issued pursuant to the exercise of an Option shall be such
price as is determined by the Administrator and set forth in the Option Agreement, but shall be subject to the following: 
 (i) In the
case of an Incentive Stock Option 
 (A) granted to an Employee who at the time of grant is a Ten Percent Holder, the per Share exercise
price shall be no less than 110% of the Fair Market Value on the date of grant; 
 (B) granted to any other Employee, the per Share
exercise price shall be no less than 100% of the Fair Market Value on the date of grant; 
 (ii) In the case of a Nonstatutory Stock Option
the per Share exercise price shall be no less than 100% of the Fair Market Value on the date of grant; 
 (iii) Notwithstanding the
foregoing, Options may be granted with a per Share exercise price other than as required above pursuant to a merger or other corporate transaction. 

  
 -7- 

 (b) Permissible Consideration. The consideration to be paid for the Shares to be
issued upon exercise of an Option, including the method of payment, shall be determined by the Administrator (and, in the case of an Incentive Stock Option and to the extent required by Applicable Laws, shall be determined at the time of grant) and
may consist entirely of (1) cash; (2) check; (3) to the extent permitted under Applicable Laws, delivery of a promissory note with such recourse, interest, security and redemption provisions as the Administrator determines to be
appropriate (subject to the provisions of Section 409 of the California Corporations Code); (4) cancellation of indebtedness; (5) other previously owned Shares that have a Fair Market Value on the date of surrender equal to the
aggregate exercise price of the Shares as to which the Option is exercised; (6) a Cashless Exercise; (7) such other consideration and method of payment permitted under Applicable Laws; or (8) any combination of the foregoing methods
of payment. In making its determination as to the type of consideration to accept, the Administrator shall consider if acceptance of such consideration may be reasonably expected to benefit the Company and the Administrator may, in its sole
discretion, refuse to accept a particular form of consideration at the time of any Option exercise. 
 10. Exercise of Option.

 (a) General. 

(i) Exercisability. Any Option granted hereunder shall be exercisable at such times and under such conditions as determined by
the Administrator, consistent with the terms of the Plan and reflected in the Option Agreement, including vesting requirements and/or performance criteria with respect to the Company, and Parent, Affiliate or Subsidiary, and/or the Optionee. 

(ii) Leave of Absence. The Administrator shall have the discretion to determine whether and to what extent the vesting of
Options shall be tolled during any unpaid leave of absence; provided, however, that in the absence of such determination, vesting of Options shall be tolled during any such unpaid leave (unless otherwise required by the Applicable Laws).
Notwithstanding the foregoing, in the event of military leave, vesting shall toll during any unpaid portion of such leave, provided that, upon a Optionee’s returning from military leave (under conditions that would entitle him or her to
protection upon such return under the Uniform Services Employment and Reemployment Rights Act), he or she shall be given vesting credit with respect to Options to the same extent as would have applied had the Optionee continued to provide services
to the Company (or any Parent or Subsidiary, if applicable) throughout the leave on the same terms as he or she was providing services immediately prior to such leave. 

(iii) Minimum Exercise Requirements. An Option may not be exercised for a fraction of a Share. The Administrator may require
that an Option be exercised as to a minimum number of Shares, provided that such requirement shall not prevent an Optionee from exercising the full number of Shares as to which the Option is then exercisable. 

(iv) Procedures for and Results of Exercise. An Option shall be deemed exercised when written notice of such exercise has been
received by the Company in accordance with the terms of the Option Agreement by the person entitled to exercise the Option and the Company has received full payment for the Shares with respect to which the Option is exercised and has paid, or made
arrangements to satisfy, any applicable withholding requirements in accordance with Section 12 below. The exercise of an Option shall result in a decrease in the number of Shares that thereafter may be available, both for purposes of the Plan
and for sale under the Option, by the number of Shares as to which the Option is exercised. 
 (v) Rights as Holder of Capital
Stock. Until the issuance of the Shares (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a holder of
capital stock shall exist with 

  
 -8- 

 
respect to the Optioned Stock, notwithstanding the exercise of the Option. No adjustment will be made for a dividend or other right for which the record date is prior to the date the stock
certificate is issued, except as provided in Section 14 below. 
 (b) Termination of Employment or Consulting
Relationship. The Administrator shall establish and set forth in the applicable Option Agreement the terms and conditions upon which an Option shall remain exercisable, if at all, following termination of an Optionee’s Continuous
Service Status, which provisions maybe waived or modified by the Administrator at any time. To the extent that an Option Agreement does not specify the terms and conditions upon which an Option shall terminate upon termination of an Optionee’s
Continuous Service Status, the following provisions shall apply: 
 (i) General Provisions. If the Optionee (or other person
entitled to exercise the Option) does not exercise the Option to the extent so entitled within the time specified below, the Option shall terminate and the Optioned Stock underlying the unexercised portion of the Option shall revert to the Plan. In
no event may any Option be exercised after the expiration of the Option term as set forth in the Option Agreement (and subject to Section 7). 

(ii) Termination other than Upon Disability or Death or for Cause. In the event of termination of an Optionee’s Continuous
Service Status other than under the circumstances set forth in subsections (iii) through (v) below, such Optionee may exercise any outstanding Option at any time within three (3) months following such termination to the extent the
Optionee is vested in the Optioned Stock. 
 (iii) Disability of Optionee. In the event of termination of an Optionee’s
Continuous Service Status as a result of his or her Disability, such Optionee may exercise any outstanding Option at any time within twelve (12) months following such termination to the extent the Optionee is vested in the Optioned Stock. 

(iv) Death of Optionee. In the event of the death of an Optionee during the period of Continuous Service Status since the date
of grant of any outstanding Option, or within three (3) months following termination of Optionee’s Continuous Service Status (other than under the circumstances set forth in subsection (v) below), the Option may be exercised by the
Optionee’s estate, or by a person who acquired the right to exercise the Option by bequest or inheritance, at any time within twelve (12) months following the date of death or, if earlier, the date the Optionee’s Continuous Service
Status terminated, but only to the extent the Optionee is vested in the Optioned Stock. 
 (v) Termination for Cause. In the
event of termination of an Optionee’s Continuous Service Status for Cause, any outstanding Option (including any vested portion thereof) held by such Optionee shall immediately terminate in its entirety upon first notification to the Optionee
of termination of the Optionee’s Continuous Service Status for Cause. If an Optionee’s Continuous Service Status is suspended pending an investigation of whether the Optionee’s Continuous Service Status will be terminated for Cause,
all the Optionee’s rights under any Option, including the right to exercise the Option, shall be suspended during the investigation period. Nothing in this Section 10(b)(v) shall in any way limit the Company’s right to purchase
unvested Shares issued upon exercise of an Option as set forth in the applicable Option Agreement. 
 (c) Buyout Provisions.
The Administrator may at any time offer to buy out for a payment in cash or Shares an Option previously granted under the Plan based on such terms and conditions as the Administrator shall establish and communicate to the Optionee at the time that
such offer is made. 

  
 -9- 

 11. Restricted Stock. 

(a) Rights to Purchase. When a right to purchase Restricted Stock is granted under the Plan, the Administrator shall advise the
recipient in writing of the terms, conditions and restrictions related to the offer, including the number of Shares that such person shall be entitled to purchase, the price to be paid (which shall be as determined by the Administrator, subject to
Applicable Laws, including any applicable securities laws), and the time within which such person must accept such offer. The permissible consideration for Restricted Stock shall be determined by the Administrator and shall be the same as is set
forth in Section 9(b) with respect to exercise of Options. The offer to purchase Shares shall be accepted by execution of a Restricted Stock Purchase Agreement in the form determined by the Administrator. 

(b) Repurchase Option. 

(i) General. Unless the Administrator determines otherwise, the Restricted Stock Purchase Agreement shall grant the Company a
repurchase option exercisable upon the voluntary or involuntary termination of the Participant’s Continuous Service Status for any reason (including death or Disability). The purchase price for Shares repurchased pursuant to the Restricted
Stock Purchase Agreement shall be the original purchase price paid by the purchaser and may be paid by cancellation of any indebtedness of the purchaser to the Company. The repurchase option shall lapse at such rate as the Administrator may
determine. 
 (ii) Leave of Absence. The Administrator shall have the discretion to determine whether and to what extent the
lapsing of Company repurchase rights shall be tolled during any unpaid leave of absence; provided, however, that in the absence of such determination, such lapsing shall be tolled during any such unpaid leave (unless otherwise required by the
Applicable Laws). Notwithstanding the foregoing, in the event of military leave, the lapsing of Company repurchase rights shall toll during any unpaid portion of such leave, provided that, upon a Participant’s returning from military leave
(under conditions that would entitle him or her to protection upon such return under the Uniform Services Employment and Reemployment Rights Act), he or she shall be given vesting credit with respect to Shares purchased pursuant to the Restricted
Stock Purchase Agreement to the same extent as would have applied had the Participant continued to provide services to the Company (or any Parent or Subsidiary, if applicable) throughout the leave on the same terms as he or she was providing
services immediately prior to such leave. 
 (c) Other Provisions. The Restricted Stock Purchase Agreement shall contain such
other terms, provisions and conditions not inconsistent with the Plan as may be determined by the Administrator in its sole discretion. In addition, the provisions of Restricted Stock Purchase Agreements need not be the same with respect to each
Participant. 
 (d) Rights as a Holder of Capital Stock. Once the Restricted Stock is purchased, the Participant shall have
the rights equivalent to those of a holder of capital stock, and shall be a record holder when his or her purchase is entered upon the records of the duly authorized transfer agent of the Company. No adjustment will be made for a dividend or other
right for which the record date is prior to the date the Restricted Stock is purchased, except as provided in Section 14 of the Plan. 

12. Taxes. 
 (a) As
a condition of the grant, vesting and exercise of an Award, the Participant (or in the case of the Participant’s death or a permitted transferee, the person holding or exercising the Award) shall make such arrangements as the Administrator may
require for the satisfaction of any applicable U.S. federal, state or local tax withholding obligations or foreign tax withholding obligations that may arise in connection with such Award. The Company shall not be required to issue any Shares under
the Plan until such obligations are satisfied. 

  
 -10- 

 (b) The Administrator may permit a Participant (or in the case of the Participant’s death or
a permitted transferee, the person holding or exercising the Award) to satisfy all or part of his or her tax withholding obligations by Cashless Exercise or by surrendering Shares (either directly or by stock attestation) that he or she previously
acquired; provided that, unless the Cashless Exercise is an approved broker-assisted Cashless Exercise, the Shares tendered for payment have been previously held for a minimum duration (e.g., to avoid financial accounting charges to the
Company’s earnings), or as otherwise permitted to avoid financial accounting charges under applicable accounting guidance, amounts withheld shall not exceed the amount necessary to satisfy the Company’s tax withholding obligations at the
minimum statutory withholding rates, including, but not limited to, U.S. federal and state income taxes, payroll taxes, and foreign taxes, if applicable. Any payment of taxes by surrendering Shares to the Company may be subject to restrictions,
including, but not limited to, any restrictions required by rules of the Securities and Exchange Commission. 
 (c) Notwithstanding anything
to the contrary contained in this Plan, to the extent that the Administrator determines that any Award granted under this Plan is subject to Code Section 409A and unless otherwise specified in the applicable Award agreement, the agreement
evidencing such Award shall incorporate terms and conditions that are intended to avoid the consequences described in Code Section 409A(a)(1), and to the maximum extent permitted under Applicable Law (and unless otherwise stated in the
applicable Award agreement), this Plan and the Award agreements shall be interpreted in a manner that results in their conforming to the requirements of Code Section 409A(a)(2), (3) and (4) and any Department of Treasury or Internal
Revenue Service regulations or other interpretive guidance issued under Section 409A (whenever issued, the “Guidance”). Notwithstanding anything to the contrary in this Plan (and unless the Award agreement provides otherwise,
with specific reference to this sentence), to the extent that a Participant holding an Award that constitutes “deferred compensation” under Section 409A and the Guidance is a “specified employee” (also as defined
thereunder), no distribution or payment of any amount shall be made before a date that is six (6) months following the date of such Participant’s “separation from service” (as defined in Section 409A and the Guidance) or, if
earlier, the date of the Participant’s death. 
 (d) The Administrator may in its discretion and upon such terms and conditions as it
determines appropriate permit one or more Participants whom it selects to (i) defer compensation payable pursuant to the terms of an Award, or (ii) defer compensation arising outside the terms of this Plan pursuant to a program that
provides for deferred payment in satisfaction of such other compensation amounts through the issuance of one or more Awards. Any such deferral arrangement shall be evidenced by an Award agreement in such form as the Administrator shall from time to
time establish, and no such deferral arrangement shall be a valid and binding obligation unless evidenced by a fully executed Award agreement, the form of which the Administrator has approved, including through the Administrator’s establishing
a written program (the “Program”) under this Plan to govern the form of Award agreements participating in such Program. Any such Award agreement or Program shall specify the treatment of dividends or dividend equivalent rights (if
any) that apply to Awards governed thereby, and shall further provide that any elections governing payment of amounts pursuant to such Program shall be in writing, shall be delivered to the Company or its agent in a form and manner intended to
comply with Code Section 409A and the Guidance, and shall specify the amount to be distributed in settlement of the deferral arrangement, as well as the time and form of such distribution in a manner intended to comply with Code
Section 409A and the Guidance. 

  
 -11- 

 13. Non-Transferability of Options. 

(a) General. Except as set forth in this Section 13, Options may not be sold, pledged, assigned, hypothecated, transferred
or disposed of in any manner other than by will or by the laws of descent or distribution. The designation of a beneficiary by an Optionee will not constitute a transfer. An Option may be exercised, during the lifetime of the holder of the Option,
only by such holder or a transferee permitted by this Section 13. 
 (b) Limited Transferability Rights. Notwithstanding
anything else in this Section 13, the Administrator may in its sole discretion grant Nonstatutory Stock Options that may, if so specified in the applicable Option Agreement, be transferred by instrument to an inter vivos or testamentary trust
in which the Options are to be passed to beneficiaries upon the death of the trustor (settlor) or by gift to Family Members. 
 14.
Adjustments Upon Changes in Capitalization, Merger or Certain Other Transactions. 
 (a) Changes in
Capitalization. Subject to any action required under Applicable Laws by the holders of capital stock of the Company, (i) the numbers and class of Shares or other stock or securities: (x) available for future Awards under
Section 3 above, and (y) covered by each outstanding Award, (ii) the price per Share covered by each such outstanding Option, and (iii) any repurchase price per Share applicable to Shares issued pursuant to any Award, shall be
proportionately adjusted by the Administrator in the event of a stock split, reverse stock split, stock dividend, combination, consolidation, recapitalization (including a recapitalization through a large nonrecurring cash dividend) or
reclassification of the Shares, subdivision of the Shares, a rights offering, a reorganization, merger, spin-off, split-up, change in corporate structure or other similar occurrence. Any adjustment by the Administrator pursuant to this
Section 14(a) shall be made in the Administrator’s sole and absolute discretion and shall be final, binding and conclusive. Except as expressly provided herein, no issuance by the Company of shares of stock of any class, or securities
convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of Shares subject to an Award. If, by reason of a transaction described in this Section 14(a) or
an adjustment pursuant to this Section 14(a), a Participant’s Award agreement or agreement related to any Optioned Stock or Restricted Stock covers additional or different shares of stock or securities, then such additional or different
shares, and the Award agreement or agreement related to the Optioned Stock or Restricted Stock in respect thereof, shall be subject to all of the terms, conditions and restrictions which were applicable to the Award, Optioned Stock and Restricted
Stock prior to such adjustment. 
 (b) Dissolution or Liquidation. In the event of the dissolution or liquidation of the
Company, each Award will terminate immediately prior to the consummation of such action, unless otherwise determined by the Administrator. 

(c) Corporate Transactions. In the event of a sale of all or substantially all of the Company’s assets, or a merger,
consolidation or other capital reorganization or business combination transaction of the Company with or into another corporation, entity or person (a “Corporate Transaction”), each outstanding Option shall either be
(i) assumed or an equivalent option or right shall be substituted by such successor corporation or a parent or subsidiary of such successor corporation (the “Successor Corporation”), or (ii) terminated in exchange for a
payment of cash, securities and/or other property equal to the excess of the Fair Market Value of the portion of the Optioned Stock that is vested and exercisable immediately prior to the consummation of the Corporate Transaction over the per Share
exercise price thereof. Notwithstanding the foregoing, in the event such Successor Corporation does not agree to such assumption, substitution or exchange, each such Option shall terminate upon the consummation of the Corporate Transaction. 

  
 -12- 

 15. Time of Granting Options and Right to Purchase Restricted Stock. The date of
grant of an Award shall, for all purposes, be the date on which the Administrator makes the determination granting such Award, or such other date as is determined by the Administrator, provided that in the case of any Incentive Stock Option, the
grant date shall be the later of the date on which the Administrator makes the determination granting such Incentive Stock Option or the date of commencement of the Optionee’s employment relationship with the Company. 

16. Amendment and Termination of the Plan. The Board may at any time amend or terminate the Plan, but no amendment or
termination (other than an adjustment pursuant to Section 14 above) shall be made that would materially and adversely affect the rights of any Participant under any outstanding Award, without his or her consent. In addition, to the extent
necessary and desirable to comply with the Applicable Laws, the Company shall obtain the approval of holders of capital stock with respect to any Plan amendment in such a manner and to such a degree as required. 

17. Conditions Upon Issuance of Shares. Notwithstanding any other provision of the Plan or any agreement entered into by the
Company pursuant to the Plan, the Company shall not be obligated, and shall have no liability for failure, to issue or deliver any Shares under the Plan unless such issuance or delivery would comply with the Applicable Laws, with such compliance
determined by the Company in consultation with its legal counsel. As a condition to the exercise of any Option or purchase of any Restricted Stock, the Company may require the person exercising the Option or purchasing the Restricted Stock to
represent and warrant at the time of any such exercise or purchase that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a
representation is required by Applicable Laws. Shares issued upon exercise of Options or purchase of Restricted Stock prior to the date, if ever, on which the Common Stock becomes a Listed Security shall be subject to a right of first refusal in
favor of the Company pursuant to which the Participant will be required to offer Shares to the Company before selling or transferring them to any third party on such terms and subject to such conditions as is reflected in the applicable Option
Agreement or Restricted Stock Purchase Agreement. 
 18. Beneficiaries. Unless stated otherwise in an Award agreement, a
Participant may designate one or more beneficiaries with respect to an Award by timely filing the prescribed form with the Company. A beneficiary designation may be changed by filing the prescribed form with the Company at any time before the
Participant’s death. If no beneficiary was designated or if no designated beneficiary survives the Participant, then after a Participant’s death any vested Award(s) shall be transferred or distributed to the Participant’s estate. 

19. Approval of Holders of Capital Stock. If required by the Applicable Laws, continuance of the Plan shall be subject to
approval by the holders of capital stock of the Company within twelve (12) months before or after the date the Plan is adopted or, to the extent required by Applicable Laws, any date the Plan is amended. Such approval shall be obtained in the
manner and to the degree required under the Applicable Laws. 
 20. Addenda. The Administrator may approve such addenda to the
Plan as it may consider necessary or appropriate for the purpose of granting Awards to Employees or Consultants, which Awards may contain such terms and conditions as the Administrator deems necessary or appropriate to accommodate differences in
local law, tax policy or custom, which, if so required under Applicable Laws, may deviate from the terms and conditions set forth in this Plan. The terms of any such addenda shall supersede the terms of the Plan to the extent necessary to
accommodate such differences but shall not otherwise affect the terms of the Plan as in effect for any other purpose. 

  
 -13- 

 ADDENDUM A 

2009 STOCK OPTION PLAN 

(California Participants) 

Prior to the date, if ever, on which the Common Stock becomes a Listed Security and/or the Company is subject to the reporting requirements of
the Exchange Act, the terms set forth herein shall apply to Awards issued to California Participants. All capitalized terms used herein but not otherwise defined shall have the respective meanings set forth in the Plan. 

1. The following rules shall apply to any Option in the event of termination of the Participant’s Continuous Service Status: 

(a) If such termination was for reasons other than death, “disability” (as defined below), or Cause, the Participant shall have at
least thirty (30) days after the date of such termination to exercise his or her Option to the extent the Participant is entitled to exercise on his or her termination date, provided that in no event shall the Option be exercisable after the
expiration of the Option term as set forth in the Option Agreement. 
 (b) If such termination was due to death or disability, the
Participant shall have at least six (6) months after the date of such termination to exercise his or her Option to the extent the Participant is entitled to exercise on his or her termination date, provided that in no event shall the Option be
exercisable after the expiration of the Option term as set forth in the Option Agreement. 
 “Disability” for purposes of this Addendum shall mean
the inability of the Participant, in the opinion of a qualified physician acceptable to the Company, to perform the major duties of the Participant’s position with the Company or any Parent or Subsidiary because of the sickness of injury of the
Participant. 
 2. Notwithstanding anything stated herein to the contrary, no Option shall be exercisable on or after the tenth anniversary
of the date of grant and any Award agreement shall terminate on or before the tenth anniversary of the date of grant. 
 3. The Company
shall furnish summary financial information (audited or unaudited) of the Company’s financial condition and results of operations, consistent with the requirements of Applicable Laws, at least annually to each California Participant during the
period such Participant has one or more Awards outstanding, and in the case of an individual who acquired Shares pursuant to the Plan, during the period such Participant owns such Shares. The Company shall not be required to provide such information
if (i) the issuance is limited to key employees whose duties in connection with the Company assure their access to equivalent information or (ii) the Plan or any agreement complies with all conditions of Rule 701 of the Securities Act of
1933, as amended; provided that for purposes of determining such compliance, any registered domestic partner shall be considered a “family member” as that term is defined in Rule 701. 

 MINDBODY, INC. 

2009 STOCK OPTION PLAN 

NOTICE OF STOCK OPTION GRANT 
  

	
	  

	
	  

	
	  

 You have been granted an option to purchase Common Stock of Mindbody, Inc., a California corporation (the
“Company”), as follows: 
  

			
	Date of Grant:		
		
	Exercise Price Per Share:		$            
		
	Total Number of Shares:		
		
	Total Exercise Price:		$            
		
	Type of Option:		             Incentive Stock Option
		
			             Non-statutory Stock Option
		
	Expiration Date:		
		
	First Vesting Date:		
		
	Vesting/Exercise Schedule:		
		
	Termination Period:		You may exercise this Option for 3 months after termination of your Continuous Service Status except as set out in Section 5 of the Stock Option Agreement (but in no event later than the Expiration Date). You are responsible
for keeping track of these exercise periods following the termination of your Continuous Service Status for any reason. The Company will not provide further notice of such periods.
		
	Transferability:		You may not transfer this Option.

 By your signature and the signature of the Company’s representative below, you and the Company agree that
this Option is granted under and governed by the terms and conditions of the Mindbody, Inc. 2009 Stock Plan, as amended, and the accompanying Stock Option Agreement, both of which are attached to and made a part of this document. 

In addition, you agree and acknowledge that your rights to any Shares underlying this Option will be earned only as you provide services to
the Company over time, that the grant of this Option is not as consideration for services you rendered to the Company prior to your date of hire, and that nothing in this Notice or the attached documents confers upon you any right to

 
continue your employment or consulting relationship with the Company for any period of time, nor does it interfere in any way with your right or the Company’s right to terminate that
relationship at any time, for any reason, with or without cause. Also, to the extent applicable, the Exercise Price Per Share has been set in good faith compliance with the applicable guidance issued by the IRS under Section 409A of the Code.
However, there is no guarantee that the IRS will agree with the valuation, and by signing below, you agree and acknowledge that the Company shall not be held liable for any applicable costs, taxes, or penalties associated with this Option if, in
fact, the IRS were to determine that this Option constitutes deferred compensation under Section 409A of the Code. You should consult with your own tax advisor concerning the tax consequences of such a determination by the IRS. 

 

			
	THE COMPANY:
	
	MINDBODY, INC.
		
	By:		  

			(Signature)
	Name:		  

	Title:		  

	
	OPTIONEE:
	
	  

	(PRINT NAME)
	
	  

	(Signature)
	
	Address:
	  

	  

	  

  
 -2- 

 MINDBODY, INC. 

2009 STOCK PLAN 

STOCK OPTION AGREEMENT 

1. Grant of Option. Mindbody, Inc., a California corporation (the “Company”), hereby grants to the
person (“Optionee”) named in the Notice of Stock Option Grant (the “Notice”), an option (the “Option”) to purchase the total number of shares of Common Stock (the “Shares”) set
forth in the Notice, at the exercise price per Share set forth in the Notice (the “Exercise Price”) subject to the terms, definitions and provisions of the Mindbody, Inc. 2009 Stock Plan, as amended (the “Plan”),
adopted by the Company, which is incorporated in this Stock Option Agreement (this “Agreement”) by reference. Unless otherwise defined in this Agreement, the terms used in this Agreement or the Notice shall have the meanings defined
in the Plan. 
 2. Designation of Option. This Option is intended to be an Incentive Stock Option as defined in
Section 422 of the Code only to the extent so designated in the Notice, and to the extent it is not so designated or to the extent this Option does not qualify as an Incentive Stock Option, it is intended to be a Nonstatutory Stock Option. 

Notwithstanding the above, if designated as an Incentive Stock Option, in the event that the Shares subject to this Option (and all other
Incentive Stock Options granted to Optionee by the Company or any Parent or Subsidiary, including under other plans of the Company) that first become exercisable in any calendar year have an aggregate fair market value (determined for each Share as
of the date of grant of the option covering such Share) in excess of $100,000, the Shares in excess of $100,000 shall be treated as subject to a Nonstatutory Stock Option, in accordance with Section 5(c) of the Plan. 

3. Exercise of Option. This Option shall be exercisable during its term in accordance with the Vesting/Exercise Schedule
set out in the Notice and with the provisions of Section 10 of the Plan as follows: 
 (a) Right to Exercise. 

(i) This Option may not be exercised for a fraction of a share. 

(ii) In the event of Optionee’s death, Disability or other termination of Continuous Service Status, the exercisability of this Option
is governed by Section 5 below, subject to the limitations contained in this Section 3. 
 (iii) In no event may this Option be
exercised after the Expiration Date set forth in the Notice. 

 (b) Method of Exercise. 

(i) This Option shall be exercisable by execution and delivery of the Exercise Agreement attached hereto as Exhibit A or of any
other form of written notice approved for such purpose by the Company which shall state Optionee’s election to exercise this Option, the number of Shares in respect of which this Option is being exercised, and such other representations and
agreements as to the holder’s investment intent with respect to such Shares as may be required by the Company pursuant to the provisions of the Plan. Such written notice shall be signed by Optionee and shall be delivered to the Company by such
means as are determined by the Plan Administrator in its discretion to constitute adequate delivery. The written notice shall be accompanied by payment of the aggregate Exercise Price for the purchased Shares. 

(ii) As a condition to the exercise of this Option and as further set forth in Section 12 of the Plan, Optionee agrees to make adequate
provision for federal, state or other tax withholding obligations, if any, which arise upon the grant, vesting or exercise of this Option, or disposition of Shares, whether by withholding, direct payment to the Company, or otherwise. 

(iii) The Company is not obligated, and will have no liability for failure, to issue or deliver any Shares upon exercise of this Option
unless such issuance or delivery would comply with the Applicable Laws, with such compliance determined by the Company in consultation with its legal counsel. This Option may not be exercised until such time as the Plan has been approved by the
holders of capital stock of the Company, or if the issuance of such Shares upon such exercise or the method of payment of consideration for such Shares would constitute a violation of any Applicable Laws, including any applicable U.S. federal or
state securities laws or any other law or regulation, including any rule under Part 221 of Title 12 of the Code of Federal Regulations as promulgated by the Federal Reserve Board. As a condition to the exercise of this Option, the Company
may require Optionee to make any representation and warranty to the Company as may be required by the Applicable Laws. Assuming such compliance, for income tax purposes the Shares shall be considered transferred to Optionee on the date on which this
Option is exercised with respect to such Shares. 
 (iv) Subject to compliance with Applicable Laws, this Option shall be deemed to be
exercised upon receipt by the Company of the appropriate written notice of exercise accompanied by the Exercise Price and the satisfaction of any applicable withholding obligations. 

4. Method of Payment. Payment of the Exercise Price shall be by any of the following, or a combination of the following, at the
election of Optionee: 
 (a) cash or check; 

(b) cancellation of indebtedness; 

(c) at the discretion of the Plan Administrator on a case by case basis, by surrender of other shares of Common Stock of the Company (either
directly or by stock attestation) that Optionee previously acquired and that have an aggregate Fair Market Value on the date of surrender equal to the aggregate Exercise Price of the Shares as to which this Option is being exercised; or 

  
 -2- 

 (d) at the discretion of the Plan Administrator on a case by case basis, by Cashless Exercise.

 5. Termination of Relationship. Following the date of termination of Optionee’s Continuous Service Status for any
reason (the “Termination Date”), Optionee may exercise this Option only as set forth in the Notice and this Section 5. If Optionee does not exercise this Option within the Termination Period set forth in the Notice or the
termination periods set forth below, this Option shall terminate in its entirety. In no event, may any Option be exercised after the Expiration Date of this Option as set forth in the Notice. 

(a) Termination. In the event of termination of Optionee’s Continuous Service Status other than as a result of
Optionee’s Disability or death or for Cause, Optionee may, to the extent Optionee is vested in the Optioned Stock at the date of such termination, exercise this Option during the Termination Period set forth in the Notice. 

(b) Other Terminations. In connection with any termination other than a termination covered by Section 5(a), Optionee may
exercise this Option only as described below: 
 (i) Termination upon Disability of Optionee. In the event of termination of
Optionee’s Continuous Service Status as a result of Optionee’s Disability, Optionee may, but only within six month(s) following the date of such termination, exercise this Option to the extent Optionee is vested in the Optioned Stock. 

(ii) Death of Optionee. In the event of termination of Optionee’s Continuous Service Status as a result of Optionee’s
death, or in the event of Optionee’s death within six month(s) following Optionee’s Termination Date, this Option may be exercised at any time within twelve month(s) following the date of death (or, if earlier, the date Optionee’s
Continuous Service Status terminated) by Optionee’s estate or by a person who acquired the right to exercise this Option by bequest or inheritance, but only to the extent Optionee is vested in this Option. 

(iii) Termination for Cause. In the event Optionee’s Continuous Service Status is terminated for Cause, the Option shall
terminate immediately upon such termination for Cause. In the event Optionee’s employment or consulting relationship with the Company is suspended pending investigation of whether such relationship shall be terminated for Cause, all
Optionee’s rights under the Option, including the right to exercise the Option, shall be suspended during the investigation period. 

6. Non-Transferability of Option. This Option may not be transferred in any manner otherwise than by will or by the laws of
descent or distribution and may be exercised during the lifetime of Optionee only by him or her. The terms of this Option shall be binding upon the executors, administrators, heirs, successors and assigns of Optionee. 

7. Lock-Up Agreement. In connection with the initial public offering of the Company’s securities and upon request of
the Company or the underwriters managing such 

  
 -3- 

 
offering of the Company’s securities, Optionee hereby agrees not to sell, make any short sale of, loan, grant any option for the purchase of, or otherwise dispose of any securities of the
Company (other than those included in the registration) without the prior written consent of the Company or such underwriters, as the case may be, for such period of time (not to exceed 180 days) from the effective date of such registration as may
be requested by the Company or such managing underwriters and to execute an agreement reflecting the foregoing as may be requested by the underwriters at the time of the Company’s initial public offering. In addition, upon request of the
Company or the underwriters managing a public offering of the Company’s securities (other than the initial public offering), Optionee hereby agrees to be bound by similar restrictions, and to sign a similar agreement, in connection with no more
than one additional registration statement filed within 12 months after the closing date of the initial public offering, provided that the duration of the lock-up period with respect to such additional registration shall not exceed 90 days from the
effective date of such additional registration statement. Notwithstanding the foregoing, if during the last 17 days of the restricted period, the Company issues an earnings release or material news or a material event relating to the Company occurs,
or prior to the expiration of the restricted period the Company announces that it will release earnings results during the 16-day period beginning on the last day of the restricted period, then, upon the request of the managing underwriter, to the
extent required by any FINRA rules, the restrictions imposed by this subsection shall continue to apply until the end of the third trading day following the expiration of the 15-day period beginning on the issuance of the earnings release or the
occurrence of the material news or material event. In no event will the restricted period extend beyond 216 days after the effective date of the registration statement. 

8. Corporate Transaction. Notwithstanding the above or anything in the Plan to the contrary, if, in connection with a
Corporate Transaction, the Successor Corporation does not assume or substitute for the Option, the Option shall become vested and exercisable to the extent of 100% of the Shares then unvested, effective as of immediately prior to consummation of the
Sale of the Company. 
 9. Effect of Agreement. Optionee acknowledges receipt of a copy of the Plan and represents that
he or she is familiar with the terms and provisions thereof (and has had an opportunity to consult counsel regarding the Option terms), and hereby accepts this Option and agrees to be bound by its contractual terms as set forth herein and in the
Plan. Optionee hereby agrees to accept as binding, conclusive and final all decisions and interpretations of the Plan Administrator regarding any questions relating to this Option. In the event of a conflict between the terms and provisions of the
Plan and the terms and provisions of the Notice and this Agreement, the Plan terms and provisions shall prevail. 
 10.
Miscellaneous. 
 (a) Governing Law. This Agreement and all acts and transactions pursuant
hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of California, without giving effect to principles of conflicts of law. 

(b) Entire Agreement; Enforcement of Rights. This Agreement, together with the Notice to which this Agreement is attached
and the Plan, sets forth the entire agreement 

  
 -4- 

 
and understanding of the parties relating to the subject matter herein and therein and merges all prior discussions between the parties. Except as contemplated under the Plan, no modification of
or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing signed by the parties to this Agreement. The failure by either party to enforce any rights under this Agreement shall not be
construed as a waiver of any rights of such party. 
 (c) Severability. If one or more provisions of this Agreement are
held to be unenforceable under Applicable Laws, the parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (i) such
provision shall be excluded from this Agreement, (ii) the balance of this Agreement shall be interpreted as if such provision were so excluded and (iii) the balance of this Agreement shall be enforceable in accordance with its terms. 

(d) Notices. Any notice required or permitted by this Agreement shall be in writing and shall be deemed sufficient upon
delivery, when delivered personally or by overnight courier or sent by email or fax (upon customary confirmation of receipt), or forty-eight (48) hours after being deposited in the U.S. mail as certified or registered mail with postage prepaid,
addressed to the party to be notified at such party’s address or fax number as set forth on the signature page or as subsequently modified by written notice. 

(e) Counterparts. This Option may be executed in two or more counterparts, each of which shall be deemed an original and
all of which together shall constitute one instrument. 
 (f) Successors and Assigns. The rights and benefits of this
Agreement shall inure to the benefit of, and be enforceable by the Company’s successors and assigns. The rights and obligations of Optionee under this Agreement may not be assigned without the prior written consent of the Company. 

  
 -5- 

 EXHIBIT A 

MINDBODY, INC. 
 2009
STOCK PLAN 
 EXERCISE AGREEMENT 

This Exercise Agreement (this “Agreement”) is made as of
                    , by and between Mindbody, Inc., a California corporation (the “Company”), and
                    (“Purchaser”). To the extent any capitalized terms used in this Agreement are not defined, they shall have the
meaning ascribed to them in the Company’s 2009 Stock Plan, as amended (the “Plan”). 
 1. Exercise of
Option. Subject to the terms and conditions hereof, Purchaser hereby elects to exercise his or her option to purchase                     
shares of the Common Stock (the “Shares”) of the Company under and pursuant to the Plan and the Stock Option Agreement granted              (the “Option
Agreement”). The purchase price for the Shares shall be $         per Share for a total purchase price of $        . The term “Shares” refers
to the purchased Shares and all securities received as stock dividends or splits, all securities received in replacement of the Shares in a recapitalization, merger, reorganization, exchange or the like, and all new, substituted or additional
securities or other property to which Purchaser is entitled by reason of Purchaser’s ownership of the Shares. 
 2. Time and
Place of Exercise. The purchase and sale of the Shares under this Agreement shall occur at the principal office of the Company simultaneously with the execution and delivery of this Agreement, the payment of the aggregate Exercise Price by
any method listed in Section 4 of the Option Agreement, and the satisfaction of any applicable tax withholding obligations, all in accordance with the provisions of Section 3(b) of the Option Agreement. The Company shall issue the Shares
to Purchaser by entering such Shares in Purchaser’s name as of such date in the books and records of the Company or, if applicable, a duly authorized transfer agent of the Company, against payment of the Exercise Price therefor by Purchaser. If
applicable, the Company will deliver to Purchaser a certificate representing the Shares as soon as practicable following such date. 
 3.
Limitations on Transfer. In addition to any other limitation on transfer created by applicable securities laws, Purchaser shall not assign, encumber or dispose of any interest in the Shares except in compliance with the provisions
below and applicable securities laws. 
 (a) Right of First Refusal. Before any Shares held by Purchaser or any transferee of
Purchaser (either being sometimes referred to herein as the “Holder”) may be sold or otherwise transferred (including transfer by gift or operation of law), the Company or its assignee(s) shall have a right of first refusal to
purchase the Shares on the terms and conditions set forth in this Section 3(a) (the “Right of First Refusal”). 

 (i) Notice of Proposed Transfer. The Holder of the Shares shall deliver to the
Company a written notice (the “Notice”) stating: (i) the Holder’s bona fide intention to sell or otherwise transfer such Shares; (ii) the name of each proposed purchaser or other transferee
(“Proposed Transferee”); (iii) the number of Shares to be transferred to each Proposed Transferee; and (iv) the terms and conditions of each proposed sale or transfer. The Holder shall offer the Shares at the same
price (the “Purchase Price”) and upon the same terms (or terms as similar as reasonably possible) to the Company or its assignee(s). 

(ii) Exercise of Right of First Refusal. At any time within thirty (30) days after receipt of the Notice, the Company
and/or its assignee(s) may, by giving written notice to the Holder, elect to purchase all, but not less than all, of the Shares proposed to be transferred to any one or more of the Proposed Transferees, at the Purchase Price. If the Purchase Price
includes consideration other than cash, the cash equivalent value of the non-cash consideration shall be determined by the Board in good faith. 

(iii) Payment. Payment of the Purchase Price shall be made, at the election of the Company or its assignee(s), in cash (by
check), by cancellation of all or a portion of any outstanding indebtedness, or by any combination thereof within sixty (60) days after receipt of the Notice or in the manner and at the times set forth in the Notice. 

(iv) Holder’s Right to Transfer. If all of the Shares proposed in the Notice to be transferred to a given Proposed
Transferee are not purchased by the Company and/or its assignee(s) as provided in this Section 3(a), then the Holder may sell or otherwise transfer such Shares to that Proposed Transferee at the Purchase Price or at a higher price, provided
that such sale or other transfer is consummated within one hundred twenty (120) days after the date of the Notice and provided further that any such sale or other transfer is effected in accordance with any applicable securities laws and the
Proposed Transferee agrees in writing that the provisions of this Section 3 shall continue to apply to the Shares in the hands of such Proposed Transferee. If the Shares described in the Notice are not transferred to the Proposed Transferee
within such period, or if the Holder proposes to change the price or other terms to make them more favorable to the Proposed Transferee, a new Notice shall be given to the Company, and the Company and/or its assignees shall again be offered the
Right of First Refusal before any Shares held by the Holder may be sold or otherwise transferred. 
 (v) Exception for Certain Family
Transfers. Anything to the contrary contained in this Section 3(a) notwithstanding, and provided that such transfer complies with applicable securities laws, the transfer of any or all of the Shares during Purchaser’s lifetime or
on Purchaser’s death by will or intestacy to Purchaser’s Immediate Family or a trust for the benefit of Purchaser’s Immediate Family shall be exempt from the provisions of this Section 3(a). “Immediate Family” as
used herein shall mean spouse, lineal descendant or antecedent, father, mother, brother or sister. In such case, the transferee or other recipient shall receive and hold the Shares so transferred subject to the provisions of this Section 3, and
there shall be no further transfer of such Shares except in accordance with the terms of this Section 3. 
 (b) Company’s
Right to Purchase upon Involuntary Transfer. In the event of any transfer by operation of law or other involuntary transfer (including death or divorce, but excluding a transfer to Immediate Family as set forth in Section 3(a)(v) above)
of all or a portion of the Shares by the record holder thereof, the Company shall have an option to purchase all of the Shares transferred at the greater of the purchase price paid by Purchaser 

  
 -2- 

 
pursuant to this Agreement or the Fair Market Value of the Shares on the date of transfer (as determined by the Board). Upon such a transfer, the person acquiring the Shares shall promptly notify
the Secretary of the Company of such transfer. The right to purchase such Shares shall be provided to the Company for a period of thirty (30) days following receipt by the Company of written notice by the person acquiring the Shares. 

(c) Assignment. The right of the Company to purchase any part of the Shares may be assigned in whole or in part to any holder or
holders of capital stock of the Company or other persons or organizations. 
 (d) Restrictions Binding on Transferees. All
transferees of Shares or any interest therein will receive and hold such Shares or interest subject to the provisions of this Agreement. Any sale or transfer of the Company’s Shares shall be void unless the provisions of this Agreement are
satisfied. 
 (e) Termination of Rights. The right of first refusal granted the Company by Section 3(a) above and the
option to repurchase the Shares in the event of an involuntary transfer granted the Company by Section 3(b) above shall terminate upon the first sale of Common Stock of the Company to the general public pursuant to a registration statement
filed with and declared effective by the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). Upon termination of the right of first refusal described in Section 3(a) above the
Company will remove any stop-transfer notices referred to in Section 5(b) below and related to the restrictions in this Section 3 and, if certificates are issued, a new certificate or certificates representing the Shares not repurchased
shall be issued, on request, without the legend referred to in Section 5(a)(ii) below and delivered to Purchaser. 
 4.
Investment and Taxation Representations. In connection with the purchase of the Shares, Purchaser represents to the Company the following: 

(a) Purchaser is aware of the Company’s business affairs and financial condition and has acquired sufficient information about the
Company to reach an informed and knowledgeable decision to acquire the Shares. Purchaser is purchasing these securities for investment for his or her own account only and not with a view to, or for resale in connection with, any
“distribution” thereof within the meaning of the Securities Act or under any applicable provision of state law. Purchaser does not have any present intention to transfer the Shares to any person or entity. 

(b) Purchaser understands that the Shares have not been registered under the Securities Act by reason of a specific exemption therefrom, which
exemption depends upon, among other things, the bona fide nature of Purchaser’s investment intent as expressed herein. 
 (c) Purchaser
further acknowledges and understands that the securities must be held indefinitely unless they are subsequently registered under the Securities Act or an exemption from such registration is available. Purchaser further acknowledges and understands
that the Company is under no obligation to register the securities. Purchaser understands that the certificate(s) evidencing the securities will be imprinted with a legend which prohibits the transfer of the securities unless they are registered or
such registration is not required in the opinion of counsel for the Company. 

  
 -3- 

 (d) Purchaser is familiar with the provisions of Rules 144 and 701, each promulgated under
the Securities Act, which, in substance, permit limited public resale of “restricted securities” acquired, directly or indirectly, from the issuer of the securities (or from an affiliate of such issuer), in a non-public offering subject to
the satisfaction of certain conditions. Purchaser understands that the Company provides no assurances as to whether he or she will be able to resell any or all of the Shares pursuant to Rule 144 or Rule 701, which rules require, among other things,
that the Company be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, that resales of securities take place only after the holder of the Shares has held the Shares for certain specified time periods, and under
certain circumstances, that resales of securities be limited in volume and take place only pursuant to brokered transactions. Notwithstanding this paragraph (d), Purchaser acknowledges and agrees to the restrictions set forth in paragraph
(e) below. 
 (e) Purchaser further understands that in the event all of the applicable requirements of Rule 144 or 701 are not
satisfied, registration under the Securities Act, compliance with Regulation A, or some other registration exemption will be required; and that, notwithstanding the fact that Rules 144 and 701 are not exclusive, the Staff of the Securities
and Exchange Commission has expressed its opinion that persons proposing to sell private placement securities other than in a registered offering and otherwise than pursuant to Rule 144 or 701 will have a substantial burden of proof in
establishing that an exemption from registration is available for such offers or sales, and that such persons and their respective brokers who participate in such transactions do so at their own risk. 

(f) Purchaser understands that Purchaser may suffer adverse tax consequences as a result of Purchaser’s purchase or disposition of the
Shares. Purchaser represents that Purchaser has consulted any tax consultants Purchaser deems advisable in connection with the purchase or disposition of the Shares and that Purchaser is not relying on the Company for any tax advice. 

5. Restrictive Legends and Stop-Transfer Orders. 

(a) Legends. The certificate or certificates representing the Shares shall bear the following legends (as well as any legends
required by applicable state and federal corporate and securities laws): 
  

	 	(i)	“THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF.
NO SUCH SALE OR DISTRIBUTION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.”

  
 -4- 

	 	(ii)	“THE SHARES REPRESENTED BY THIS CERTIFICATE MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND THE STOCKHOLDER, A COPY OF WHICH IS ON FILE WITH AND MAY BE OBTAINED FROM THE
SECRETARY OF THE COMPANY.” 

 (b) Stop-Transfer Notices. Purchaser agrees that, in order to ensure
compliance with the restrictions referred to herein, the Company may issue appropriate “stop transfer” instructions to its transfer agent, if any, and that, if the Company transfers its own securities, it may make appropriate notations to
the same effect in its own records. 
 (c) Refusal to Transfer. The Company shall not be required (i) to transfer on its
books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Agreement or (ii) to treat as owner of such Shares or to accord the right to vote or pay dividends to any purchaser or other transferee
to whom such Shares shall have been so transferred. 
 6. No Employment Rights. Nothing in this Agreement shall affect in any
manner whatsoever the right or power of the Company, or a parent or subsidiary of the Company, to terminate Purchaser’s employment or consulting relationship, for any reason, with or without cause. 

7. Lock-Up Agreement. In connection with the initial public offering of the Company’s securities and upon request of the
Company or the underwriters managing such offering of the Company’s securities, Purchaser hereby agrees not to sell, make any short sale of, loan, grant any option for the purchase of, or otherwise dispose of any securities of the Company
(other than those included in the registration) without the prior written consent of the Company or such underwriters, as the case may be, for such period of time (not to exceed 180 days) from the effective date of such registration as may be
requested by the Company or such managing underwriters and to execute an agreement reflecting the foregoing as may be requested by the underwriters at the time of the Company’s initial public offering. In addition, upon request of the Company
or the underwriters managing a public offering of the Company’s securities (other than the initial public offering), Purchaser hereby agrees to be bound by similar restrictions, and to sign a similar agreement, in connection with no more than
one additional registration statement filed within 12 months after the closing date of the initial public offering, provided that the duration of the lock-up period with respect to such additional registration shall not exceed 90 days from the
effective date of such additional registration statement. Notwithstanding the foregoing, if during the last 17 days of the restricted period, the Company issues an earnings release or material news or a material event relating to the Company occurs,
or prior to the expiration of the restricted period the Company announces that it will release earnings results during the 16-day period beginning on the last day of the restricted period, then, upon the request of the managing underwriter, to the
extent required by any FINRA rules, the restrictions imposed by this subsection shall continue to apply until the end of the third trading day following the expiration of the 15-day period beginning on the issuance of the earnings release or the
occurrence of the material news or material event. In no event will the restricted period extend beyond 216 days after the effective date of the registration statement. 

  
 -5- 

 8. Miscellaneous. 

(a) Governing Law. This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties
hereto shall be governed, construed and interpreted in accordance with the laws of the State of California, without giving effect to principles of conflicts of law. 

(b) Entire Agreement; Enforcement of Rights. This Agreement sets forth the entire agreement and understanding of the parties
relating to the subject matter herein and merges all prior discussions between them. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing signed by the parties to
this Agreement. The failure by either party to enforce any rights under this Agreement shall not be construed as a waiver of any rights of such party. 

(c) Severability. If one or more provisions of this Agreement are held to be unenforceable under Applicable Laws, the parties
agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (i) such provision shall be excluded from this Agreement, (ii) the
balance of the Agreement shall be interpreted as if such provision were so excluded and (iii) the balance of the Agreement shall be enforceable in accordance with its terms. 

(d) Notices. Any notice required or permitted by this Agreement shall be in writing and shall be deemed sufficient upon
delivery, when delivered personally or by overnight courier or sent by email or fax (upon customary confirmation of receipt), or forty-eight (48) hours after being deposited in the U.S. mail as certified or registered mail with postage prepaid,
addressed to the party to be notified at such party’s address or fax number as set forth on the signature page or as subsequently modified by written notice. 

(e) Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original and all
of which together shall constitute one instrument. 
 (f) Successors and Assigns. The rights and benefits of this Agreement
shall inure to the benefit of, and be enforceable by the Company’s successors and assigns. The rights and obligations of Purchaser under this Agreement may only be assigned with the prior written consent of the Company. 

(g) California Corporate Securities Law. THE SALE OF THE SECURITIES WHICH ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN
QUALIFIED WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES
IS EXEMPT FROM QUALIFICATION BY SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT. 

  
 -6- 

 The parties have executed this Exercise Agreement as of the date first set forth above. 

 

			
	THE COMPANY:
	
	MINDBODY, INC.
		
	By:		  

			(Signature)
		
	Name: 		  

		
	Title:		  

	
	 Address:
 4051 Broad Street,
Suite 220
 California, CA 93401
 United States

Fax: (866) 759-7958

	
	OPTIONEE:
	
	  

	(PRINT NAME)
	
	  

	(Signature)
	
	Address:
	
	  

	
	  

	
	  

		
	Fax:		  

		
	email:		  

  
 -7- 

 I,
                                , spouse of
                                 (“Purchaser”), have read and hereby
approve the foregoing Agreement. In consideration of the Company’s granting my spouse the right to purchase the Shares as set forth in the Agreement, I hereby agree to be irrevocably bound by the Agreement and further agree that any community
property or similar interest that I may have in the Shares shall be similarly bound by the Agreement. I hereby appoint my spouse as my attorney-in-fact with respect to any amendment or exercise of any rights under the Agreement. 

 

	
	  

	Spouse of Purchaser (if applicable)

  
 -8-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}]]